BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still CD, Gerhard GS, Han X, Dziura J. Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA. 2011;108:16381-16385. [PMID: 21930939 DOI: 10.1073/pnas.1113359108] [Cited by in Crossref: 365] [Cited by in F6Publishing: 356] [Article Influence: 33.2] [Reference Citation Analysis]
Number Citing Articles
1 Lee DU, Han J, Lee KJ, Kwon J, Fan GH, Jung D, Urrunaga NH. The clinical implications of pre-liver transplant diabetes on post-liver transplant outcomes in patients with NASH: analysis of the UNOS database. Hepatol Int. [DOI: 10.1007/s12072-022-10414-8] [Reference Citation Analysis]
2 Xiao J, Li X, Zhou Z, Guan S, Zhuo L, Gao B. Development of an in vitro insulin resistance dissociated model of hepatic steatosis by co-culture system. Biosci Trends 2022. [PMID: 35965099 DOI: 10.5582/bst.2022.01242] [Reference Citation Analysis]
3 Li X, Zhen M, Zhou C, Yu M, Liu L, Shu C, Wang C. Dual regulation on oxidative stress and endoplasmic reticulum stress by [70] fullerenes for reversing insulin resistance in diabetes. Nano Today 2022;45:101541. [DOI: 10.1016/j.nantod.2022.101541] [Reference Citation Analysis]
4 Yin H, Shi A, Wu J. Platelet-Activating Factor Promotes the Development of Non-Alcoholic Fatty Liver Disease. Diabetes Metab Syndr Obes 2022;15:2003-30. [PMID: 35837578 DOI: 10.2147/DMSO.S367483] [Reference Citation Analysis]
5 Shao G, Liu Y, Lu L, Zhang G, Zhou W, Wu T, Wang L, Xu H, Ji G. The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products. Front Pharmacol 2022;13:944088. [DOI: 10.3389/fphar.2022.944088] [Reference Citation Analysis]
6 Alshehade S, Alshawsh MA, Murugaiyah V, Asif M, Alshehade O, Almoustafa H, Al Zarzour RH. The role of protein kinases as key drivers of metabolic dysfunction-associated fatty liver disease progression: New insights and future directions. Life Sci 2022;:120732. [PMID: 35760093 DOI: 10.1016/j.lfs.2022.120732] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Flessa C, Kyrou I, Nasiri‐ansari N, Kaltsas G, Kassi E, Randeva HS. Endoplasmic reticulum stress in nonalcoholic (metabolic associated) fatty liver disease (NAFLD/MAFLD). J of Cellular Biochemistry. [DOI: 10.1002/jcb.30247] [Reference Citation Analysis]
8 Mu X, Qi S, Wang H, Yuan L, Wang C, Li Y, Qiu J. Bisphenol analogues induced metabolic effects through eliciting intestinal cell heterogeneous response. Environment International 2022. [DOI: 10.1016/j.envint.2022.107287] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Almeida LM, Pinho BR, Duchen MR, Oliveira JMA. The PERKs of mitochondria protection during stress: insights for PERK modulation in neurodegenerative and metabolic diseases. Biol Rev Camb Philos Soc 2022. [PMID: 35475315 DOI: 10.1111/brv.12860] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang C, Zhao Z, Deng X, Cai Z, Gu T, Li L, Guo C, Wang D, Yang L, Zhao L, Yuan G. Association of triglyceride-glucose with cardiac hemodynamics in type 2 diabetes. Diabetes and Vascular Disease Research 2022;19:147916412210833. [DOI: 10.1177/14791641221083396] [Reference Citation Analysis]
11 Qiao L, Men L, Yu S, Yao J, Li Y, Wang M, Yu Y, Wang N, Ran L, Wu Y, Du J. Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance. Cell Death Dis 2022;13:275. [PMID: 35347118 DOI: 10.1038/s41419-022-04716-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Li D, Zhu Y, Wang Y, Zou Q, Duan J, Sun-waterhouse D, Sun B. Perspectives on diacylglycerol-induced improvement of insulin sensitivity in type 2 diabetes. Food Science and Human Wellness 2022;11:230-7. [DOI: 10.1016/j.fshw.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Han JE, Shin HB, Ahn YH, Cho HJ, Cheong JY, Park B, Kim SS. Relationship between the dynamics of non-alcoholic fatty liver disease and incident diabetes mellitus. Sci Rep 2022;12:2538. [PMID: 35169195 DOI: 10.1038/s41598-022-06205-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zambon Azevedo V, Silaghi CA, Maurel T, Silaghi H, Ratziu V, Pais R. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease. Front Nutr 2022;8:774030. [DOI: 10.3389/fnut.2021.774030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Singh SP, Anirvan P, Khandelwal R, Satapathy SK. Nonalcoholic Fatty Liver Disease (NAFLD) Name Change: Requiem or Reveille? J Clin Transl Hepatol 2021;9:931-8. [PMID: 34966656 DOI: 10.14218/JCTH.2021.00174] [Reference Citation Analysis]
16 Xu L, Liu W, Bai F, Xu Y, Liang X, Ma C, Gao L. Hepatic Macrophage as a Key Player in Fatty Liver Disease. Front Immunol 2021;12:708978. [PMID: 34956171 DOI: 10.3389/fimmu.2021.708978] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Lampignano L, Donghia R, Griseta C, Lagravinese G, Sciarra S, Zupo R, Castellana F, Bortone I, Guerra V, Tirelli S, De Nucci S, Tatoli R, Lozupone M, Sborgia G, Leo A, De Pergola G, Giannelli G, Panza F, Sardone R. Liver Health and Dementia in an Italian Older Population: Findings From the Salus in Apulia Study. Front Aging Neurosci 2021;13:748888. [PMID: 34955810 DOI: 10.3389/fnagi.2021.748888] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
18 Huh JY, Saltiel AR. Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease. Exp Mol Med 2021;53:1697-705. [PMID: 34848839 DOI: 10.1038/s12276-021-00712-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Hoene M, Kappler L, Kollipara L, Hu C, Irmler M, Bleher D, Hoffmann C, Beckers J, Hrabě de Angelis M, Häring HU, Birkenfeld AL, Peter A, Sickmann A, Xu G, Lehmann R, Weigert C. Exercise prevents fatty liver by modifying the compensatory response of mitochondrial metabolism to excess substrate availability. Mol Metab 2021;:101359. [PMID: 34695608 DOI: 10.1016/j.molmet.2021.101359] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Willis SA, Bawden SJ, Malaikah S, Sargeant JA, Stensel DJ, Aithal GP, King JA. The role of hepatic lipid composition in obesity-related metabolic disease. Liver Int 2021. [PMID: 34547171 DOI: 10.1111/liv.15059] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
21 Dai W, Zhang Z, Zhao S. The Risk of Type 2 Diabetes and Coronary Artery Disease in Non-obese Patients With Non-alcoholic Fatty Liver Disease: A Cohort Study. Front Cardiovasc Med 2021;8:680664. [PMID: 34490362 DOI: 10.3389/fcvm.2021.680664] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Biagioli M, Fiorucci S. Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease. Liver Research 2021;5:119-41. [DOI: 10.1016/j.livres.2021.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Rogacka D. Insulin resistance in glomerular podocytes: Potential mechanisms of induction. Arch Biochem Biophys 2021;710:109005. [PMID: 34371008 DOI: 10.1016/j.abb.2021.109005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Zhang X, Xu D, Chen M, Wang Y, He L, Wang L, Wu J, Yin J. Impacts of Selected Dietary Nutrient Intakes on Skeletal Muscle Insulin Sensitivity and Applications to Early Prevention of Type 2 Diabetes. Adv Nutr 2021;12:1305-16. [PMID: 33418570 DOI: 10.1093/advances/nmaa161] [Reference Citation Analysis]
25 von Loeffelholz C, Coldewey SM, Birkenfeld AL. A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies. Cells 2021;10:1822. [PMID: 34359991 DOI: 10.3390/cells10071822] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
26 Wang X, Liu D, Wang Z, Cai C, Jiang H, Yu G. Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. FASEB J 2021;35:e21458. [PMID: 33948987 DOI: 10.1096/fj.202000763RRR] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Yki-Järvinen H, Luukkonen PK, Hodson L, Moore JB. Dietary carbohydrates and fats in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34257427 DOI: 10.1038/s41575-021-00472-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 23.0] [Reference Citation Analysis]
28 Geidl-flueck B, Hochuli M, Németh Á, Eberl A, Derron N, Köfeler HC, Tappy L, Berneis K, Spinas GA, Gerber PA. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial. Journal of Hepatology 2021;75:46-54. [DOI: 10.1016/j.jhep.2021.02.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
29 Li H, Yu XH, Ou X, Ouyang XP, Tang CK. Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis. Prog Lipid Res 2021;83:101109. [PMID: 34097928 DOI: 10.1016/j.plipres.2021.101109] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
30 Chen Q, Zhao L, Mei L, Zhong R, Han P, Yang H, Li Q, Li J. Association of sex hormones with hepatic steatosis in men with chronic hepatitis B. Dig Liver Dis 2021:S1590-8658(21)00273-5. [PMID: 34116975 DOI: 10.1016/j.dld.2021.05.022] [Reference Citation Analysis]
31 Karkucinska-Wieckowska A, Simoes ICM, Kalinowski P, Lebiedzinska-Arciszewska M, Zieniewicz K, Milkiewicz P, Górska-Ponikowska M, Pinton P, Malik AN, Krawczyk M, Oliveira PJ, Wieckowski MR. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. Eur J Clin Invest 2021;:e13622. [PMID: 34050922 DOI: 10.1111/eci.13622] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Albhaisi S, Sanyal AJ. Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis. Front Endocrinol (Lausanne) 2021;12:665987. [PMID: 34040583 DOI: 10.3389/fendo.2021.665987] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol 2021;18:599-612. [PMID: 33972770 DOI: 10.1038/s41575-021-00448-y] [Cited by in Crossref: 60] [Cited by in F6Publishing: 72] [Article Influence: 60.0] [Reference Citation Analysis]
34 Bassendine MF, Taylor-Robinson SD, Fertleman M, Khan M, Neely D. Is Alzheimer's Disease a Liver Disease of the Brain? J Alzheimers Dis 2020;75:1-14. [PMID: 32250293 DOI: 10.3233/JAD-190848] [Cited by in Crossref: 6] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
35 Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 2021;184:2537-64. [PMID: 33989548 DOI: 10.1016/j.cell.2021.04.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 164] [Article Influence: 10.0] [Reference Citation Analysis]
36 Walchuk C, Wang Y, Suh M. The impact of EPA and DHA on ceramide lipotoxicity in the metabolic syndrome. Br J Nutr 2021;125:863-75. [PMID: 32792029 DOI: 10.1017/S0007114520003177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci 2021;22:4156. [PMID: 33923817 DOI: 10.3390/ijms22084156] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
38 Santoro A, McGraw TE, Kahn BB. Insulin action in adipocytes, adipose remodeling, and systemic effects. Cell Metab 2021;33:748-57. [PMID: 33826917 DOI: 10.1016/j.cmet.2021.03.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
39 Wiȩckowska-Gacek A, Mietelska-Porowska A, Chutorański D, Wydrych M, Długosz J, Wojda U. Western Diet Induces Impairment of Liver-Brain Axis Accelerating Neuroinflammation and Amyloid Pathology in Alzheimer's Disease. Front Aging Neurosci 2021;13:654509. [PMID: 33867971 DOI: 10.3389/fnagi.2021.654509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
40 Zhang M, Ceyhan Y, Kaftanovskaya EM, Vasquez JL, Vacher J, Knop FK, Nathanson L, Agoulnik AI, Ittmann MM, Agoulnik IU. INPP4B protects from metabolic syndrome and associated disorders. Commun Biol 2021;4:416. [PMID: 33772116 DOI: 10.1038/s42003-021-01940-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Flessa CM, Kyrou I, Nasiri-Ansari N, Kaltsas G, Papavassiliou AG, Kassi E, Randeva HS. Endoplasmic Reticulum Stress and Autophagy in the Pathogenesis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Evidence and Perspectives. Curr Obes Rep 2021;10:134-61. [PMID: 33751456 DOI: 10.1007/s13679-021-00431-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
42 Armandi A, Rosso C, Caviglia GP, Bugianesi E. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites 2021;11:155. [PMID: 33800465 DOI: 10.3390/metabo11030155] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
43 Yang Z, Mi J, Wang Y, Xue L, Liu J, Fan M, Zhang D, Wang L, Qian H, Li Y. Effects of low-carbohydrate diet and ketogenic diet on glucose and lipid metabolism in type 2 diabetic mice. Nutrition 2021;89:111230. [PMID: 33838492 DOI: 10.1016/j.nut.2021.111230] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
44 Zhu Y, Li Y, Bai B, Shang C, Fang J, Cong J, Li W, Li S, Song G, Liu Z, Zhao J, Li X, Zhu G, Jin N. Effects of Apoptin-Induced Endoplasmic Reticulum Stress on Lipid Metabolism, Migration, and Invasion of HepG-2 Cells. Front Oncol 2021;11:614082. [PMID: 33718168 DOI: 10.3389/fonc.2021.614082] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Hajduch E, Lachkar F, Ferré P, Foufelle F. Roles of Ceramides in Non-Alcoholic Fatty Liver Disease. J Clin Med 2021;10:792. [PMID: 33669443 DOI: 10.3390/jcm10040792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
46 Cariou B, Byrne CD, Loomba R, Sanyal AJ. Nonalcoholic fatty liver disease as a metabolic disease in humans: A literature review. Diabetes Obes Metab 2021;23:1069-83. [PMID: 33464677 DOI: 10.1111/dom.14322] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 41.0] [Reference Citation Analysis]
47 Kurauti MA, Soares GM, Marmentini C, Bronczek GA, Branco RCS, Boschero AC. Insulin and aging. Vitam Horm 2021;115:185-219. [PMID: 33706949 DOI: 10.1016/bs.vh.2020.12.010] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
48 Gariani K, Jornayvaz FR. Pathophysiology of NASH in endocrine diseases. Endocr Connect 2021;10:R52-65. [PMID: 33449917 DOI: 10.1530/EC-20-0490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
49 Kang DW, Hwang WC, Noh YN, Che X, Lee SH, Jang Y, Choi KY, Choi JY, Min DS. Deletion of phospholipase D1 decreases bone mass and increases fat mass via modulation of Runx2, β-catenin-osteoprotegerin, PPAR-γ and C/EBPα signaling axis. Biochim Biophys Acta Mol Basis Dis 2021;1867:166084. [PMID: 33497821 DOI: 10.1016/j.bbadis.2021.166084] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
50 London A, Lundsgaard AM, Kiens B, Bojsen-Møller KN. The Role of Hepatic Fat Accumulation in Glucose and Insulin Homeostasis-Dysregulation by the Liver. J Clin Med 2021;10:390. [PMID: 33498493 DOI: 10.3390/jcm10030390] [Reference Citation Analysis]
51 Semova I, Biddinger SB. Triglycerides in Nonalcoholic Fatty Liver Disease: Guilty Until Proven Innocent. Trends Pharmacol Sci 2021;42:183-90. [PMID: 33468321 DOI: 10.1016/j.tips.2020.12.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
52 Xian YX, Weng JP, Xu F. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diagnosis, and pharmacotherapy. Chin Med J (Engl). 2020;134:8-19. [PMID: 33323806 DOI: 10.1097/cm9.0000000000001263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
53 Ter Horst KW, Vatner DF, Zhang D, Cline GW, Ackermans MT, Nederveen AJ, Verheij J, Demirkiran A, van Wagensveld BA, Dallinga-Thie GM, Nieuwdorp M, Romijn JA, Shulman GI, Serlie MJ. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease. Diabetes Care 2021;44:489-98. [PMID: 33293347 DOI: 10.2337/dc20-1644] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
54 Li X, Zhang D, Vatner DF, Goedeke L, Hirabara SM, Zhang Y, Perry RJ, Shulman GI. Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice. Proc Natl Acad Sci U S A 2020;117:32584-93. [PMID: 33293421 DOI: 10.1073/pnas.1922169117] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
55 Li X, Wang H. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease. Cell Biosci 2020;10:140. [PMID: 33372630 DOI: 10.1186/s13578-020-00507-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
56 Qiu Y, Deng X, Sha Y, Wu X, Zhang P, Chen K, Zhao Z, Wei W, Yang L, Yuan G, Zhao L, Wang D. Visceral Fat Area, Not Subcutaneous Fat Area, is Associated with Cardiac Hemodynamics in Type 2 Diabetes. Diabetes Metab Syndr Obes 2020;13:4413-22. [PMID: 33235479 DOI: 10.2147/DMSO.S284420] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
57 Pafili K, Roden M. Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans. Mol Metab 2021;50:101122. [PMID: 33220492 DOI: 10.1016/j.molmet.2020.101122] [Cited by in Crossref: 6] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
58 Khateeb S, Albalawi A, Alkhedaide A. Regulatory effect of diosgenin on lipogenic genes expression in high-fat diet-induced obesity in mice. Saudi J Biol Sci 2021;28:1026-32. [PMID: 33424396 DOI: 10.1016/j.sjbs.2020.11.045] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
59 Guo S, Gong L, Shen Q, Xing D. Photobiomodulation reduces hepatic lipogenesis and enhances insulin sensitivity through activation of CaMKKβ/AMPK signaling pathway. J Photochem Photobiol B 2020;213:112075. [PMID: 33152638 DOI: 10.1016/j.jphotobiol.2020.112075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Mohammed ED, Abdel-Naim AB, Kangpeng J, Jiang R, Wei J, Sun B. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. Life Sci 2021;264:118615. [PMID: 33096115 DOI: 10.1016/j.lfs.2020.118615] [Reference Citation Analysis]
61 Winters SJ, Scoggins CR, Appiah D, Ghooray DT. The hepatic lipidome and HNF4α and SHBG expression in human liver. Endocr Connect 2020;9:1009-18. [PMID: 33064664 DOI: 10.1530/EC-20-0401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
62 Song L, Li Y, Qu D, Ouyang P, Ding X, Wu P, Guan Q, Yang L. The regulatory effects of phytosterol esters (PSEs) on gut flora and faecal metabolites in rats with NAFLD. Food Funct 2020;11:977-91. [PMID: 31803887 DOI: 10.1039/c9fo01570a] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
63 Myronovych A, Bhattacharjee J, Salazar-Gonzalez RM, Tan B, Mowery S, Ferguson D, Ryan KK, Zhang W, Zhao X, Oehrle M, Setchell KD, Seeley RJ, Sandoval DA, Kohli R. Assessment of the role of FGF15 in mediating the metabolic outcomes of murine Vertical Sleeve Gastrectomy (VSG). Am J Physiol Gastrointest Liver Physiol 2020. [PMID: 32967428 DOI: 10.1152/ajpgi.00175.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
64 Joo JH, Kim HJ, Park EC, Jang SI. Association between sitting time and non-alcoholic fatty live disease in South Korean population: a cross-sectional study. Lipids Health Dis 2020;19:212. [PMID: 32967678 DOI: 10.1186/s12944-020-01385-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
65 Sim JA, Kim J, Yang D. Beyond Lipid Signaling: Pleiotropic Effects of Diacylglycerol Kinases in Cellular Signaling. Int J Mol Sci 2020;21:E6861. [PMID: 32962151 DOI: 10.3390/ijms21186861] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
66 Acierno C, Caturano A, Pafundi PC, Nevola R, Adinolfi LE, Sasso FC. Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin. Exploration of Medicine 2020;1. [DOI: 10.37349/emed.2020.00019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Abulizi A, Vatner DF, Ye Z, Wang Y, Camporez JP, Zhang D, Kahn M, Lyu K, Sirwi A, Cline GW, Hussain MM, Aspichueta P, Samuel VT, Shulman GI. Membrane-bound sn-1,2-diacylglycerols explain the dissociation of hepatic insulin resistance from hepatic steatosis in MTTP knockout mice. J Lipid Res 2020;61:1565-76. [PMID: 32907986 DOI: 10.1194/jlr.RA119000586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
68 Lyu K, Zhang Y, Zhang D, Kahn M, Ter Horst KW, Rodrigues MRS, Gaspar RC, Hirabara SM, Luukkonen PK, Lee S, Bhanot S, Rinehart J, Blume N, Rasch MG, Serlie MJ, Bogan JS, Cline GW, Samuel VT, Shulman GI. A Membrane-Bound Diacylglycerol Species Induces PKCϵ-Mediated Hepatic Insulin Resistance. Cell Metab 2020;32:654-664.e5. [PMID: 32882164 DOI: 10.1016/j.cmet.2020.08.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 36] [Article Influence: 9.0] [Reference Citation Analysis]
69 Shao M, Ye Z, Qin Y, Wu T. Abnormal metabolic processes involved in the pathogenesis of non-alcoholic fatty liver disease (Review). Exp Ther Med 2020;20:26. [PMID: 32934691 DOI: 10.3892/etm.2020.9154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
70 Lonardo A, Leoni S, Alswat KA, Fouad Y. History of Nonalcoholic Fatty Liver Disease. Int J Mol Sci 2020;21:E5888. [PMID: 32824337 DOI: 10.3390/ijms21165888] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 21.5] [Reference Citation Analysis]
71 Dorling JL, Ravussin E, Redman LM, Bhapkar M, Huffman KM, Racette SB, Das SK, Apolzan JW, Kraus WE, Höchsmann C, Martin CK; CALERIE Phase 2 Study Group. Effect of 2 years of calorie restriction on liver biomarkers: results from the CALERIE phase 2 randomized controlled trial. Eur J Nutr 2021;60:1633-43. [PMID: 32803412 DOI: 10.1007/s00394-020-02361-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
72 Sangwung P, Petersen KF, Shulman GI, Knowles JW. Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications. Endocrinology 2020;161:bqaa017. [PMID: 32060542 DOI: 10.1210/endocr/bqaa017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 33] [Article Influence: 8.0] [Reference Citation Analysis]
73 Cornejo MA, Nguyen J, Cazares J, Escobedo B, Nishiyama A, Nakano D, Ortiz RM. Partial Body Mass Recovery After Caloric Restriction Abolishes Improved Glucose Tolerance in Obese, Insulin Resistant Rats. Front Endocrinol (Lausanne) 2020;11:363. [PMID: 32587574 DOI: 10.3389/fendo.2020.00363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
74 Bacle A, Kadri L, Khoury S, Ferru-Clément R, Faivre JF, Cognard C, Bescond J, Krzesiak A, Contzler H, Delpech N, Colas J, Vandebrouck C, Sébille S, Ferreira T. A comprehensive study of phospholipid fatty acid rearrangements in metabolic syndrome: correlations with organ dysfunction. Dis Model Mech 2020;13:dmm043927. [PMID: 32303571 DOI: 10.1242/dmm.043927] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
75 Lee D, Shin Y, Roh JS, Ahn J, Jeoong S, Shin SS, Yoon M. Lemon Balm Extract ALS-L1023 Regulates Obesity and Improves Insulin Sensitivity via Activation of Hepatic PPARα in High-Fat Diet-Fed Obese C57BL/6J Mice. Int J Mol Sci 2020;21:E4256. [PMID: 32549364 DOI: 10.3390/ijms21124256] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
76 Zhang J, Powell CA, Kay MK, Park MH, Meruvu S, Sonkar R, Choudhury M. A moderate physiological dose of benzyl butyl phthalate exacerbates the high fat diet-induced diabesity in male mice. Toxicol Res (Camb) 2020;9:353-70. [PMID: 32905190 DOI: 10.1093/toxres/tfaa037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
77 Zhang CH, Zhou BG, Sheng JQ, Chen Y, Cao YQ, Chen C. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. Pharmacol Res 2020;159:104984. [PMID: 32502637 DOI: 10.1016/j.phrs.2020.104984] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
78 Nardo AD, Grün NG, Zeyda M, Dumanic M, Oberhuber G, Rivelles E, Helbich TH, Markgraf DF, Roden M, Claudel T, Trauner M, Stulnig TM. Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma. Liver Int 2020;40:1620-33. [PMID: 32281248 DOI: 10.1111/liv.14464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
79 Lytle KA, Bush NC, Triay JM, Kellogg TA, Kendrick ML, Swain JM, Gathaiya NW, Hames KC, Jensen MD. Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity. J Clin Endocrinol Metab 2019;104:6171-81. [PMID: 31408176 DOI: 10.1210/jc.2019-00875] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
80 Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep 2020;2:100101. [PMID: 32514497 DOI: 10.1016/j.jhepr.2020.100101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
81 Villalva-Pérez JM, Ramírez-Vargas MA, Serafín-Fabían JI, Ramírez M, Elena Moreno-Godínez M, Espinoza-Rojo M, Flores-Alfaro E. Characterization of Huh7 cells after the induction of insulin resistance and post-treatment with metformin. Cytotechnology 2020;72:499-511. [PMID: 32409919 DOI: 10.1007/s10616-020-00398-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
82 Goedeke L, Perry RJ, Shulman GI. Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes. Annu Rev Pharmacol Toxicol 2019;59:65-87. [PMID: 30625285 DOI: 10.1146/annurev-pharmtox-010716-104727] [Cited by in Crossref: 28] [Cited by in F6Publishing: 36] [Article Influence: 14.0] [Reference Citation Analysis]
83 Romacho T, Sell H, Indrakusuma I, Roehrborn D, Castañeda TR, Jelenik T, Markgraf D, Hartwig S, Weiss J, Al-hasani H, Roden M, Eckel J. DPP4 deletion in adipose tissue improves hepatic insulin sensitivity in diet-induced obesity. American Journal of Physiology-Endocrinology and Metabolism 2020;318:E590-9. [DOI: 10.1152/ajpendo.00323.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
84 Dong B, Zhou Y, Wang W, Scott J, Kim K, Sun Z, Guo Q, Lu Y, Gonzales NM, Wu H, Hartig SM, York RB, Yang F, Moore DD. Vitamin D Receptor Activation in Liver Macrophages Ameliorates Hepatic Inflammation, Steatosis, and Insulin Resistance in Mice. Hepatology 2020;71:1559-74. [PMID: 31506976 DOI: 10.1002/hep.30937] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 20.5] [Reference Citation Analysis]
85 Zhao W, Liu Y, Liao X, Zhao S. The Role of Overexpressed Apolipoprotein AV in Insulin-Resistant Hepatocytes. Biomed Res Int 2020;2020:3268505. [PMID: 32382544 DOI: 10.1155/2020/3268505] [Reference Citation Analysis]
86 Ramírez-higuera A, Peña-montes C, Herrera-meza S, Mendoza-lópez R, Valerio-alfaro G, Oliart-ros RM. Preventive Action of Sterculic Oil on Metabolic Syndrome Development on a Fructose-Induced Rat Model. Journal of Medicinal Food 2020;23:305-11. [DOI: 10.1089/jmf.2019.0177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
87 Chakravarthy MV, Neuschwander-Tetri BA. The metabolic basis of nonalcoholic steatohepatitis. Endocrinol Diabetes Metab 2020;3:e00112. [PMID: 33102794 DOI: 10.1002/edm2.112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
88 Schmitz-Peiffer C. Deconstructing the Role of PKC Epsilon in Glucose Homeostasis. Trends Endocrinol Metab 2020;31:344-56. [PMID: 32305097 DOI: 10.1016/j.tem.2020.01.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
89 Wu X, Chen K, Williams KJ. An oxide transport chain essential for balanced insulin action. Atherosclerosis 2020;298:42-51. [PMID: 32171979 DOI: 10.1016/j.atherosclerosis.2020.02.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
90 Hari A, Fealy CE, Axelrod CL, Haus JM, Flask CA, McCullough AJ, Kirwan JP. Exercise Training Rapidly Increases Hepatic Insulin Extraction in NAFLD. Med Sci Sports Exerc 2020;52:1449-55. [PMID: 32028458 DOI: 10.1249/MSS.0000000000002273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
91 Petersen MC, Samuel VT, Petersen KF, Shulman GI. Non‐alcoholic Fatty Liver Disease and Insulin Resistance. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS, Wolkoff AW, editors. The Liver. Wiley; 2020. pp. 455-71. [DOI: 10.1002/9781119436812.ch37] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
92 van den Hoek AM, Pieterman EJ, van der Hoorn JW, Iruarrizaga-Lejarreta M, Alonso C, Verschuren L, Skjæret T, Princen HMG, Fraser DA. Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice. Hepatol Commun 2020;4:193-207. [PMID: 32025605 DOI: 10.1002/hep4.1453] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
93 Rivers SL, Klip A, Giacca A. NOD1: An Interface Between Innate Immunity and Insulin Resistance. Endocrinology 2019;160:1021-30. [PMID: 30807635 DOI: 10.1210/en.2018-01061] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
94 Razak Hady H, Błachnio-Zabielska AU, Szczerbiński Ł, Zabielski P, Imierska M, Dadan J, Krętowski AJ. Ceramide Content in Liver Increases Along with Insulin Resistance in Obese Patients. J Clin Med 2019;8:E2197. [PMID: 31842461 DOI: 10.3390/jcm8122197] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
95 Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature 2019;576:51-60. [PMID: 31802013 DOI: 10.1038/s41586-019-1797-8] [Cited by in Crossref: 172] [Cited by in F6Publishing: 271] [Article Influence: 57.3] [Reference Citation Analysis]
96 Chen Y, Chen J, Zhang C, Yang S, Zhang X, Liu Y, Su Z. Deficiency in the short-chain acyl-CoA dehydrogenase protects mice against diet-induced obesity and insulin resistance. The FASEB Journal 2019;33:13722-33. [DOI: 10.1096/fj.201901474rr] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
97 Akhtar DH, Iqbal U, Vazquez-Montesino LM, Dennis BB, Ahmed A. Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2019;7:362-370. [PMID: 31915606 DOI: 10.14218/jcth.2019.00028] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
98 Xu L, Nagata N, Ota T. Impact of Glucoraphanin-Mediated Activation of Nrf2 on Non-Alcoholic Fatty Liver Disease with a Focus on Mitochondrial Dysfunction. Int J Mol Sci 2019;20:E5920. [PMID: 31775341 DOI: 10.3390/ijms20235920] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
99 Simoes ICM, Janikiewicz J, Bauer J, Karkucinska-Wieckowska A, Kalinowski P, Dobrzyń A, Wolski A, Pronicki M, Zieniewicz K, Dobrzyń P, Krawczyk M, Zischka H, Wieckowski MR, Potes Y. Fat and Sugar-A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease. Nutrients 2019;11:E2871. [PMID: 31771244 DOI: 10.3390/nu11122871] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
100 Yang S, Kwak S, Lee JH, Kang S, Lee SP. Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population. PLoS One 2019;14:e0224626. [PMID: 31682638 DOI: 10.1371/journal.pone.0224626] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
101 Olaniyi KS, Olatunji LA. Oral ethinylestradiol–levonorgestrel normalizes fructose-induced hepatic lipid accumulation and glycogen depletion in female rats. Can J Physiol Pharmacol 2019;97:1042-52. [DOI: 10.1139/cjpp-2019-0037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
102 Patel BM, Goyal RK. Liver and insulin resistance: New wine in old bottle!!! European Journal of Pharmacology 2019;862:172657. [DOI: 10.1016/j.ejphar.2019.172657] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
103 Kaur S, Rawal P, Siddiqui H, Rohilla S, Sharma S, Tripathi DM, Baweja S, Hassan M, Vlaic S, Guthke R, Thomas M, Dayoub R, Bihari C, Sarin SK, Weiss TS. Increased Expression of RUNX1 in Liver Correlates with NASH Activity Score in Patients with Non-Alcoholic Steatohepatitis (NASH). Cells 2019;8:E1277. [PMID: 31635436 DOI: 10.3390/cells8101277] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
104 Kalmykova ZA, Kononenko IV, Mayorov AY. [Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis]. Ter Arkh 2019;91:106-11. [PMID: 32598639 DOI: 10.26442/00403660.2019.10.000165] [Reference Citation Analysis]
105 Bril F, Barb D, Lomonaco R, Lai J, Cusi K. Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis. J Hepatol 2020;72:401-10. [PMID: 31589891 DOI: 10.1016/j.jhep.2019.09.018] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
106 Ruiz-Ojeda FJ, Méndez-Gutiérrez A, Aguilera CM, Plaza-Díaz J. Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases. Int J Mol Sci 2019;20:E4888. [PMID: 31581657 DOI: 10.3390/ijms20194888] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 26.7] [Reference Citation Analysis]
107 Chen S, Henderson A, Petriello MC, Romano KA, Gearing M, Miao J, Schell M, Sandoval-Espinola WJ, Tao J, Sha B, Graham M, Crooke R, Kleinridders A, Balskus EP, Rey FE, Morris AJ, Biddinger SB. Trimethylamine N-Oxide Binds and Activates PERK to Promote Metabolic Dysfunction. Cell Metab 2019; 30: 1141-1151. e5. [PMID: 31543404 DOI: 10.1016/j.cmet.2019.08.021] [Cited by in Crossref: 59] [Cited by in F6Publishing: 101] [Article Influence: 19.7] [Reference Citation Analysis]
108 Gancheva S, Ouni M, Jelenik T, Koliaki C, Szendroedi J, Toledo FGS, Markgraf DF, Pesta DH, Mastrototaro L, De Filippo E, Herder C, Jähnert M, Weiss J, Strassburger K, Schlensak M, Schürmann A, Roden M. Dynamic changes of muscle insulin sensitivity after metabolic surgery. Nat Commun 2019;10:4179. [PMID: 31519890 DOI: 10.1038/s41467-019-12081-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
109 Van de Velde F, Bekaert M, Geerts A, Hoorens A, Batens AH, Shadid S, Ouwens M, Van Nieuwenhove Y, Lapauw B. Insulin resistance associates with hepatic lobular inflammation in subjects with obesity. Endocr Connect 2019;8:1294-301. [PMID: 31470414 DOI: 10.1530/EC-19-0366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
110 Zhu S, Tian Z, Torigoe D, Zhao J, Xie P, Sugizaki T, Sato M, Horiguchi H, Terada K, Kadomatsu T, Miyata K, Oike Y. Aging- and obesity-related peri-muscular adipose tissue accelerates muscle atrophy. PLoS One 2019;14:e0221366. [PMID: 31442231 DOI: 10.1371/journal.pone.0221366] [Cited by in Crossref: 23] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
111 Massart J, Zierath JR. Role of Diacylglycerol Kinases in Glucose and Energy Homeostasis. Trends Endocrinol Metab 2019;30:603-17. [PMID: 31331711 DOI: 10.1016/j.tem.2019.06.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
112 Ahn B, Wan S, Jaiswal N, Vega RB, Ayer DE, Titchenell PM, Han X, Won KJ, Kelly DP. MondoA drives muscle lipid accumulation and insulin resistance. JCI Insight 2019;5:129119. [PMID: 31287806 DOI: 10.1172/jci.insight.129119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
113 Gharaibeh NE, Rahhal MN, Rahimi L, Ismail-Beigi F. SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directions. Diabetes Metab Syndr Obes 2019;12:1001-12. [PMID: 31308716 DOI: 10.2147/DMSO.S212715] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
114 Gupta AP, Singh P, Garg R, Valicherla GR, Riyazuddin M, Syed AA, Hossain Z, Gayen JR. Pancreastatin inhibitor activates AMPK pathway via GRP78 and ameliorates dexamethasone induced fatty liver disease in C57BL/6 mice. Biomed Pharmacother. 2019;116:108959. [PMID: 31108350 DOI: 10.1016/j.biopha.2019.108959] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
115 Abildgaard J, Danielsen ER, Dorph E, Thomsen C, Juul A, Ewertsen C, Pedersen BK, Pedersen AT, Ploug T, Lindegaard B. Ectopic Lipid Deposition Is Associated With Insulin Resistance in Postmenopausal Women. J Clin Endocrinol Metab 2018;103:3394-404. [PMID: 29889238 DOI: 10.1210/jc.2018-00554] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
116 Abulizi A, Camporez JP, Jurczak MJ, Høyer KF, Zhang D, Cline GW, Samuel VT, Shulman GI, Vatner DF. Adipose glucocorticoid action influences whole-body metabolism via modulation of hepatic insulin action. FASEB J 2019;33:8174-85. [PMID: 30922125 DOI: 10.1096/fj.201802706R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
117 Preuss C, Jelenik T, Bódis K, Müssig K, Burkart V, Szendroedi J, Roden M, Markgraf DF. A New Targeted Lipidomics Approach Reveals Lipid Droplets in Liver, Muscle and Heart as a Repository for Diacylglycerol and Ceramide Species in Non-Alcoholic Fatty Liver. Cells 2019;8:E277. [PMID: 30909521 DOI: 10.3390/cells8030277] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
118 Li WD, Xia JR, Lian YS. Hepatic miR‑215 target Rictor and modulation of hepatic insulin signalling in rats. Mol Med Rep 2019;19:3723-31. [PMID: 30896868 DOI: 10.3892/mmr.2019.10031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
119 Sanghera DK, Bejar C, Sharma S, Gupta R, Blackett PR. Obesity genetics and cardiometabolic health: Potential for risk prediction. Diabetes Obes Metab 2019;21:1088-100. [PMID: 30667137 DOI: 10.1111/dom.13641] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
120 Uche IK, Galiana G. Distinguishing Lipid Subtypes by Amplifying Contrast from J-Coupling. Sci Rep 2019;9:3600. [PMID: 30837532 DOI: 10.1038/s41598-019-39780-4] [Reference Citation Analysis]
121 Yang W, Yang M, Yao H, Ma Y, Ren X, Teng L, Wang T. Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease. J Int Med Res 2019;47:1250-63. [PMID: 30678506 DOI: 10.1177/0300060518813058] [Reference Citation Analysis]
122 Prins GH, Luangmonkong T, Oosterhuis D, Mutsaers HAM, Dekker FJ, Olinga P. A Pathophysiological Model of Non-Alcoholic Fatty Liver Disease Using Precision-Cut Liver Slices. Nutrients 2019;11:E507. [PMID: 30818824 DOI: 10.3390/nu11030507] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
123 Sasako T, Ohsugi M, Kubota N, Itoh S, Okazaki Y, Terai A, Kubota T, Yamashita S, Nakatsukasa K, Kamura T, Iwayama K, Tokuyama K, Kiyonari H, Furuta Y, Shibahara J, Fukayama M, Enooku K, Okushin K, Tsutsumi T, Tateishi R, Tobe K, Asahara H, Koike K, Kadowaki T, Ueki K. Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism. Nat Commun 2019;10:947. [PMID: 30814508 DOI: 10.1038/s41467-019-08591-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
124 Olaniyi KS, Olatunji LA. Inhibition of pyruvate dehydrogenase kinase-4 by l-glutamine protects pregnant rats against fructose-induced obesity and hepatic lipid accumulation. Biomedicine & Pharmacotherapy 2019;110:59-67. [DOI: 10.1016/j.biopha.2018.11.038] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
125 Nahon JE, Hoekstra M, van Harmelen V, Rensen PC, Willems van Dijk K, Kooijman S, Van Eck M. Proteoglycan 4 deficiency protects against glucose intolerance and fatty liver disease in diet-induced obese mice. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019;1865:494-501. [DOI: 10.1016/j.bbadis.2018.11.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
126 Grycel S, Markowski AR, Hady HR, Zabielski P, Kojta I, Imierska M, Górski J, Blachnio-Zabielska AU. Metformin treatment affects adipocytokine secretion and lipid composition in adipose tissues of diet-induced insulin-resistant rats. Nutrition 2019;63-64:126-33. [PMID: 30959381 DOI: 10.1016/j.nut.2019.01.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
127 Mu W, Cheng XF, Liu Y, Lv QZ, Liu GL, Zhang JG, Li XY. Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues. Front Pharmacol 2018;9:1566. [PMID: 30692925 DOI: 10.3389/fphar.2018.01566] [Cited by in Crossref: 21] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
128 Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiol Rev. 2018;98:2133-2223. [PMID: 30067154 DOI: 10.1152/physrev.00063.2017] [Cited by in Crossref: 475] [Cited by in F6Publishing: 709] [Article Influence: 158.3] [Reference Citation Analysis]
129 Hammarstedt A, Gogg S, Hedjazifar S, Nerstedt A, Smith U. Impaired Adipogenesis and Dysfunctional Adipose Tissue in Human Hypertrophic Obesity. Physiol Rev. 2018;98:1911-1941. [PMID: 30067159 DOI: 10.1152/physrev.00034.2017] [Cited by in Crossref: 108] [Cited by in F6Publishing: 142] [Article Influence: 36.0] [Reference Citation Analysis]
130 Shang W, Li H, Strappe P, Zhou Z, Blanchard C. Konjac glucomannans attenuate diet-induced fat accumulation on livers and its regulation pathway. Journal of Functional Foods 2019;52:258-65. [DOI: 10.1016/j.jff.2018.11.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
131 Lim S, Taskinen MR, Borén J. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obes Rev 2019;20:599-611. [PMID: 30589487 DOI: 10.1111/obr.12820] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
132 Zhao Q, Xu H, Hong S, Song N, Xie J, Yan Z, Wang R, Yang P, Jiang X. Rapeseed Protein-Derived Antioxidant Peptide RAP Ameliorates Nonalcoholic Steatohepatitis and Related Metabolic Disorders in Mice. Mol Pharm 2019;16:371-81. [PMID: 30543441 DOI: 10.1021/acs.molpharmaceut.8b01030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
133 Abulizi A, Camporez JP, Zhang D, Samuel VT, Shulman GI, Vatner DF. Ectopic lipid deposition mediates insulin resistance in adipose specific 11β-hydroxysteroid dehydrogenase type 1 transgenic mice. Metabolism 2019;93:1-9. [PMID: 30576689 DOI: 10.1016/j.metabol.2018.12.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
134 Yan R, Niu CY, Tian Y. Roles of Autophagy and Protein Kinase C-epsilon in Lipid Metabolism of Nonalcoholic Fatty Liver Cell Models. Arch Med Res 2018;49:381-90. [PMID: 30573200 DOI: 10.1016/j.arcmed.2018.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
135 Gancheva S, Jelenik T, Álvarez-Hernández E, Roden M. Interorgan Metabolic Crosstalk in Human Insulin Resistance. Physiol Rev 2018;98:1371-415. [PMID: 29767564 DOI: 10.1152/physrev.00015.2017] [Cited by in Crossref: 68] [Cited by in F6Publishing: 84] [Article Influence: 17.0] [Reference Citation Analysis]
136 Blachnio-Zabielska AU, Hady HR, Markowski AR, Kurianiuk A, Karwowska A, Górski J, Zabielski P. Inhibition of Ceramide De Novo Synthesis Affects Adipocytokine Secretion and Improves Systemic and Adipose Tissue Insulin Sensitivity. Int J Mol Sci 2018;19:E3995. [PMID: 30545025 DOI: 10.3390/ijms19123995] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
137 Villalobos-Labra R, Subiabre M, Toledo F, Pardo F, Sobrevia L. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity. Mol Aspects Med 2019;66:49-61. [PMID: 30472165 DOI: 10.1016/j.mam.2018.11.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
138 Masuda S, Fujishima Y, Maeda N, Tsugawa-Shimizu Y, Nakamura Y, Tanaka Y, Obata Y, Fukuda S, Nagao H, Kita S, Nishizawa H, Shimomura I. Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity. Am J Physiol Endocrinol Metab 2019;316:E239-50. [PMID: 30457913 DOI: 10.1152/ajpendo.00319.2018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
139 Paruthiyil S, Hagiwara SI, Kundassery K, Bhargava A. Sexually dimorphic metabolic responses mediated by CRF2 receptor during nutritional stress in mice. Biol Sex Differ 2018;9:49. [PMID: 30400826 DOI: 10.1186/s13293-018-0208-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
140 Ling AV, Gearing ME, Semova I, Shin DJ, Clements R, Lai ZW, Biddinger SB. FoxO1 Is Required for Most of the Metabolic and Hormonal Perturbations Produced by Hepatic Insulin Receptor Deletion in Male Mice. Endocrinology 2018;159:1253-63. [PMID: 29300910 DOI: 10.1210/en.2017-00870] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
141 Shigiyama F, Kumashiro N, Tsuneoka Y, Igarashi H, Yoshikawa F, Kakehi S, Funato H, Hirose T. Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice. American Journal of Physiology-Endocrinology and Metabolism 2018;315:E848-58. [DOI: 10.1152/ajpendo.00072.2018] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
142 Drummen M, Dorenbos E, Vreugdenhil ACE, Raben A, Fogelholm M, Westerterp-plantenga MS, Adam TC. Long-term effects of increased protein intake after weight loss on intrahepatic lipid content and implications for insulin sensitivity: a PREVIEW study. American Journal of Physiology-Endocrinology and Metabolism 2018;315:E885-91. [DOI: 10.1152/ajpendo.00162.2018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
143 Liangpunsakul S, Chalasani N. Lipid mediators of liver injury in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol. 2019;316:G75-G81. [PMID: 30383414 DOI: 10.1152/ajpgi.00170.2018] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
144 Taylor R, Al-mrabeh A, Zhyzhneuskaya S, Peters C, Barnes AC, Aribisala BS, Hollingsworth KG, Mathers JC, Sattar N, Lean ME. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreas Fat Content but Is Dependent upon Capacity for β Cell Recovery. Cell Metabolism 2018;28:547-556.e3. [DOI: 10.1016/j.cmet.2018.07.003] [Cited by in Crossref: 111] [Cited by in F6Publishing: 126] [Article Influence: 27.8] [Reference Citation Analysis]
145 Gassaway BM, Petersen MC, Surovtseva YV, Barber KW, Sheetz JB, Aerni HR, Merkel JS, Samuel VT, Shulman GI, Rinehart J. PKCε contributes to lipid-induced insulin resistance through cross talk with p70S6K and through previously unknown regulators of insulin signaling. Proc Natl Acad Sci U S A 2018;115:E8996-9005. [PMID: 30181290 DOI: 10.1073/pnas.1804379115] [Cited by in Crossref: 26] [Cited by in F6Publishing: 35] [Article Influence: 6.5] [Reference Citation Analysis]
146 Gonzalez LL, Garrie K, Turner MD. Type 2 diabetes - An autoinflammatory disease driven by metabolic stress. Biochim Biophys Acta Mol Basis Dis. 2018;1864:3805-3823. [PMID: 30251697 DOI: 10.1016/j.bbadis.2018.08.034] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
147 Sargeant JA, Gray LJ, Bodicoat DH, Willis SA, Stensel DJ, Nimmo MA, Aithal GP, King JA. The effect of exercise training on intrahepatic triglyceride and hepatic insulin sensitivity: a systematic review and meta-analysis: Exercise, intrahepatic triglyceride and hepatic insulin sensitivity. Obesity Reviews 2018;19:1446-59. [DOI: 10.1111/obr.12719] [Cited by in Crossref: 21] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
148 Zabielski P, Daniluk J, Hady HR, Markowski AR, Imierska M, Górski J, Blachnio-Zabielska AU. The effect of high-fat diet and inhibition of ceramide production on insulin action in liver. J Cell Physiol 2019;234:1851-61. [PMID: 30067865 DOI: 10.1002/jcp.27058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
149 Metcalfe LK, Smith GC, Turner N. Defining lipid mediators of insulin resistance - controversies and challenges. J Mol Endocrinol 2018:JME-18-0023. [PMID: 30068522 DOI: 10.1530/JME-18-0023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
150 Régnier M, Polizzi A, Guillou H, Loiseau N. Sphingolipid metabolism in non-alcoholic fatty liver diseases. Biochimie 2019;159:9-22. [PMID: 30071259 DOI: 10.1016/j.biochi.2018.07.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
151 Zheng W, Zhou J, Song S, Kong W, Xia W, Chen L, Zeng T. Dipeptidyl-Peptidase 4 Inhibitor Sitagliptin Ameliorates Hepatic Insulin Resistance by Modulating Inflammation and Autophagy in ob/ob Mice.Int J Endocrinol. 2018;2018:8309723. [PMID: 30123267 DOI: 10.1155/2018/8309723] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
152 Lebeaupin C, Vallée D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol 2018;69:927-47. [PMID: 29940269 DOI: 10.1016/j.jhep.2018.06.008] [Cited by in Crossref: 198] [Cited by in F6Publishing: 292] [Article Influence: 49.5] [Reference Citation Analysis]
153 Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci 2018;75:3313-27. [PMID: 29936596 DOI: 10.1007/s00018-018-2860-6] [Cited by in Crossref: 234] [Cited by in F6Publishing: 389] [Article Influence: 58.5] [Reference Citation Analysis]
154 von Loeffelholz C, Gissey LC, Schumann T, Henke C, Kurzbach A, Struck J, Bergmann A, Hanefeld M, Schatz U, Bornstein SR, Casella G, Mingrone G, Birkenfeld AL. The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery. Int J Obes (Lond) 2018;42:2057-61. [PMID: 29795470 DOI: 10.1038/s41366-018-0084-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
155 Pacifico L, Andreoli GM, D’Avanzo M, De Mitri D, Pierimarchi P. Role of osteoprotegerin/receptor activator of nuclear factor kappa B/receptor activator of nuclear factor kappa B ligand axis in nonalcoholic fatty liver disease. World J Gastroenterol 2018; 24(19): 2073-2082 [PMID: 29785076 DOI: 10.3748/wjg.v24.i19.2073] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
156 Wang C, Li Y, Hao M, Li W. Astragaloside IV Inhibits Triglyceride Accumulation in Insulin-Resistant HepG2 Cells via AMPK-Induced SREBP-1c Phosphorylation. Front Pharmacol 2018;9:345. [PMID: 29713279 DOI: 10.3389/fphar.2018.00345] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
157 Caprio S, Pierpont B, Kursawe R. The "adipose tissue expandability" hypothesis: a potential mechanism for insulin resistance in obese youth. Horm Mol Biol Clin Investig 2018;33:/j/hmbci. [PMID: 29596053 DOI: 10.1515/hmbci-2018-0005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
158 Ter Horst KW, Gilijamse PW, Versteeg RI, Ackermans MT, Nederveen AJ, la Fleur SE, Romijn JA, Nieuwdorp M, Zhang D, Samuel VT, Vatner DF, Petersen KF, Shulman GI, Serlie MJ. Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. Cell Rep 2017;19:1997-2004. [PMID: 28591572 DOI: 10.1016/j.celrep.2017.05.035] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 19.3] [Reference Citation Analysis]
159 Shibasaki Y, Horikawa M, Ikegami K, Kiuchi R, Takeda M, Hiraide T, Morita Y, Konno H, Takeuchi H, Setou M, Sakaguchi T. Stearate-to-palmitate ratio modulates endoplasmic reticulum stress and cell apoptosis in non-B non-C hepatoma cells. Cancer Sci 2018;109:1110-20. [PMID: 29427339 DOI: 10.1111/cas.13529] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
160 Vatner DF, Goedeke L, Camporez JG, Lyu K, Nasiri AR, Zhang D, Bhanot S, Murray SF, Still CD, Gerhard GS, Shulman GI, Samuel VT. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia 2018;61:1435-46. [PMID: 29497783 DOI: 10.1007/s00125-018-4579-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 7.3] [Reference Citation Analysis]
161 Hannou SA, Haslam DE, McKeown NM, Herman MA. Fructose metabolism and metabolic disease. J Clin Invest. 2018;128:545-555. [PMID: 29388924 DOI: 10.1172/jci96702] [Cited by in Crossref: 158] [Cited by in F6Publishing: 197] [Article Influence: 39.5] [Reference Citation Analysis]
162 Agosti P, Sabbà C, Mazzocca A. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:607-17. [DOI: 10.1016/j.bbadis.2017.11.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
163 Daniele G, Winnier D, Mari A, Bruder J, Fourcaudot M, Pengou Z, Hansis-Diarte A, Jenkinson C, Tripathy D, Folli F. The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans. Acta Diabetol 2018;55:139-48. [PMID: 29151224 DOI: 10.1007/s00592-017-1065-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
164 de Castro GS, Calder PC. Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids. Clinical Nutrition 2018;37:37-55. [DOI: 10.1016/j.clnu.2017.01.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 65] [Article Influence: 13.8] [Reference Citation Analysis]
165 Dongiovanni P, Stender S, Pietrelli A, Mancina RM, Cespiati A, Petta S, Pelusi S, Pingitore P, Badiali S, Maggioni M, Mannisto V, Grimaudo S, Pipitone RM, Pihlajamaki J, Craxi A, Taube M, Carlsson LMS, Fargion S, Romeo S, Kozlitina J, Valenti L. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. J Intern Med 2018;283:356-70. [PMID: 29280273 DOI: 10.1111/joim.12719] [Cited by in Crossref: 121] [Cited by in F6Publishing: 157] [Article Influence: 24.2] [Reference Citation Analysis]
166 Ruby MA, Massart J, Hunerdosse DM, Schönke M, Correia JC, Louie SM, Ruas JL, Näslund E, Nomura DK, Zierath JR. Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance. Cell Rep 2017;18:636-46. [PMID: 28099843 DOI: 10.1016/j.celrep.2016.12.070] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 9.4] [Reference Citation Analysis]
167 Camporez JP, Wang Y, Faarkrog K, Chukijrungroat N, Petersen KF, Shulman GI. Mechanism by which arylamine N-acetyltransferase 1 ablation causes insulin resistance in mice. Proc Natl Acad Sci U S A 2017;114:E11285-92. [PMID: 29237750 DOI: 10.1073/pnas.1716990115] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
168 Zhang J, Zhao J, Zheng X, Cai K, Mao Q, Xia H. Establishment of a novel hepatic steatosis cell model by Cas9/sgRNA-mediated DGKθ gene knockout. Mol Med Rep 2018;17:2169-76. [PMID: 29207074 DOI: 10.3892/mmr.2017.8140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
169 Lonardo A, Nascimbeni F, Mantovani A, Targher G. Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? J Hepatol. 2018;68:335-352. [PMID: 29122390 DOI: 10.1016/j.jhep.2017.09.021] [Cited by in Crossref: 224] [Cited by in F6Publishing: 297] [Article Influence: 44.8] [Reference Citation Analysis]
170 Hsu MC, Wang ME, Jiang YF, Liu HC, Chen YC, Chiu CH. Long-term feeding of high-fat plus high-fructose diet induces isolated impaired glucose tolerance and skeletal muscle insulin resistance in miniature pigs. Diabetol Metab Syndr 2017;9:81. [PMID: 29046729 DOI: 10.1186/s13098-017-0281-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
171 Guo Y, Yu J, Wang C, Li K, Liu B, Du Y, Xiao F, Chen S, Guo F. miR-212-5p suppresses lipid accumulation by targeting FAS and SCD1. Journal of Molecular Endocrinology 2017;59:205-17. [DOI: 10.1530/jme-16-0179] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
172 Knebel B, Goeddeke S, Poschmann G, Markgraf DF, Jacob S, Nitzgen U, Passlack W, Preuss C, Dicken HD, Stühler K, Hartwig S, Lehr S, Kotzka J. Novel Insights into the Adipokinome of Obese and Obese/Diabetic Mouse Models. Int J Mol Sci 2017;18:E1928. [PMID: 28885548 DOI: 10.3390/ijms18091928] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
173 Qi Z, Xia J, Xue X, Liu J, Liu W, Ding S. Targeting viperin improves diet-induced glucose intolerance but not adipose tissue inflammation. Oncotarget 2017;8:101418-36. [PMID: 29254175 DOI: 10.18632/oncotarget.20724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
174 Samuel VT, Shulman GI. Nonalcoholic Fatty Liver Disease as a Nexus of Metabolic and Hepatic Diseases. Cell Metab 2018;27:22-41. [PMID: 28867301 DOI: 10.1016/j.cmet.2017.08.002] [Cited by in Crossref: 234] [Cited by in F6Publishing: 273] [Article Influence: 46.8] [Reference Citation Analysis]
175 Stafeev IS, Vorotnikov AV, Ratner EI, Menshikov MY, Parfyonova YV. Latent Inflammation and Insulin Resistance in Adipose Tissue. Int J Endocrinol 2017;2017:5076732. [PMID: 28912810 DOI: 10.1155/2017/5076732] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 7.2] [Reference Citation Analysis]
176 Shigiyama F, Kumashiro N, Furukawa Y, Funayama T, Takeno K, Wakui N, Ikehara T, Nagai H, Taka H, Fujimura T, Uchino H, Tamura Y, Watada H, Nemoto T, Shiraga N, Sumino Y, Hirose T. Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease. Hepatol Commun 2017;1:634-47. [PMID: 29404483 DOI: 10.1002/hep4.1077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
177 Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol 2017;13:572-87. [PMID: 28731034 DOI: 10.1038/nrendo.2017.80] [Cited by in Crossref: 442] [Cited by in F6Publishing: 406] [Article Influence: 88.4] [Reference Citation Analysis]
178 Park D, Kwon H, Oh SW, Joh HK, Hwang SS, Park JH, Yun JM, Lee H, Chung GE, Ze S, Park JH, Bae Y, Lee A. Is Vitamin D an Independent Risk Factor of Nonalcoholic Fatty Liver Disease? J Korean Med Sci. 2017;32:95-101. [PMID: 27914137 DOI: 10.3346/jkms.2017.32.1.95] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
179 Wang S, Wu C, Li X, Zhou Y, Zhang Q, Ma F, Wei J, Zhang X, Guo P. Syringaresinol-4-O-β-d-glucoside alters lipid and glucose metabolism in HepG2 cells and C2C12 myotubes. Acta Pharm Sin B 2017;7:453-60. [PMID: 28752030 DOI: 10.1016/j.apsb.2017.04.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
180 Meex RCR, Watt MJ. Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. Nat Rev Endocrinol. 2017;13:509-520. [PMID: 28621339 DOI: 10.1038/nrendo.2017.56] [Cited by in Crossref: 278] [Cited by in F6Publishing: 260] [Article Influence: 55.6] [Reference Citation Analysis]
181 Perla FM, Prelati M, Lavorato M, Visicchio D, Anania C. The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. Children (Basel) 2017;4:E46. [PMID: 28587303 DOI: 10.3390/children4060046] [Cited by in Crossref: 29] [Cited by in F6Publishing: 41] [Article Influence: 5.8] [Reference Citation Analysis]
182 Petersen MC, Shulman GI. Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance. Trends Pharmacol Sci. 2017;38:649-665. [PMID: 28551355 DOI: 10.1016/j.tips.2017.04.004] [Cited by in Crossref: 151] [Cited by in F6Publishing: 174] [Article Influence: 30.2] [Reference Citation Analysis]
183 Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31:936-944. [PMID: 26667191 DOI: 10.1111/jgh.13264] [Cited by in Crossref: 318] [Cited by in F6Publishing: 363] [Article Influence: 63.6] [Reference Citation Analysis]
184 Wang XX, Ye T, Li M, Li X, Qiang O, Tang CW, Liu R. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity. Mol Med Rep 2017;16:109-18. [PMID: 28534956 DOI: 10.3892/mmr.2017.6586] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
185 Jelenik T, Kaul K, Séquaris G, Flögel U, Phielix E, Kotzka J, Knebel B, Fahlbusch P, Hörbelt T, Lehr S, Reinbeck AL, Müller-Wieland D, Esposito I, Shulman GI, Szendroedi J, Roden M. Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver. Diabetes 2017;66:2241-53. [PMID: 28490610 DOI: 10.2337/db16-1147] [Cited by in Crossref: 72] [Cited by in F6Publishing: 83] [Article Influence: 14.4] [Reference Citation Analysis]
186 Gluchowski NL, Becuwe M, Walther TC, Farese RV Jr. Lipid droplets and liver disease: from basic biology to clinical implications. Nat Rev Gastroenterol Hepatol 2017;14:343-55. [PMID: 28428634 DOI: 10.1038/nrgastro.2017.32] [Cited by in Crossref: 251] [Cited by in F6Publishing: 243] [Article Influence: 50.2] [Reference Citation Analysis]
187 Pereira RM, Botezelli JD, da Cruz Rodrigues KC, Mekary RA, Cintra DE, Pauli JR, da Silva ASR, Ropelle ER, de Moura LP. Fructose Consumption in the Development of Obesity and the Effects of Different Protocols of Physical Exercise on the Hepatic Metabolism. Nutrients 2017;9:E405. [PMID: 28425939 DOI: 10.3390/nu9040405] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 8.4] [Reference Citation Analysis]
188 Ma Z, Liu H, Wang W, Guan S, Yi J, Chu L. Paeoniflorin suppresses lipid accumulation and alleviates insulin resistance by regulating the Rho kinase/IRS-1 pathway in palmitate-induced HepG2Cells. Biomed Pharmacother 2017;90:361-7. [PMID: 28380411 DOI: 10.1016/j.biopha.2017.03.087] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
189 Abulizi A, Perry RJ, Camporez JPG, Jurczak MJ, Petersen KF, Aspichueta P, Shulman GI. A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice. FASEB J 2017;31:2916-24. [PMID: 28330852 DOI: 10.1096/fj.201700001R] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 5.4] [Reference Citation Analysis]
190 Ma Z, Chu L, Liu H, Wang W, Li J, Yao W, Yi J, Gao Y. Beneficial effects of paeoniflorin on non-alcoholic fatty liver disease induced by high-fat diet in rats. Sci Rep 2017;7:44819. [PMID: 28300221 DOI: 10.1038/srep44819] [Cited by in Crossref: 32] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
191 Zand H, Morshedzadeh N, Naghashian F. Signaling pathways linking inflammation to insulin resistance. Diabetes Metab Syndr 2017;11 Suppl 1:S307-9. [PMID: 28365222 DOI: 10.1016/j.dsx.2017.03.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
192 Chen W, Balland E, Cowley MA. Hypothalamic Insulin Resistance in Obesity: Effects on Glucose Homeostasis. Neuroendocrinology 2017;104:364-81. [PMID: 28122381 DOI: 10.1159/000455865] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 10.4] [Reference Citation Analysis]
193 Li YL, Xie H, Musha H, Xing Y, Mei CX, Wang HJ, Wulasihan M. The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid. Cell Biochem Biophys 2015;72:643-7. [PMID: 27352181 DOI: 10.1007/s12013-014-0346-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
194 Li Y, Chu Y, Yu L, Kang H, Zhou L. Transcriptomic analysis of Bama pig's liver in various nutritional states reveals a metabolic difference of fatty acids. Food Funct 2017;8:3480-90. [DOI: 10.1039/c7fo00937b] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
195 Hur JH, Park SY, Dall'Armi C, Lee JS, Di Paolo G, Lee HY, Yoon MS, Min DS, Choi CS. Phospholipase D1 deficiency in mice causes nonalcoholic fatty liver disease via an autophagy defect. Sci Rep 2016;6:39170. [PMID: 27976696 DOI: 10.1038/srep39170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
196 Nandipati KC, Subramanian S, Agrawal DK. Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance. Mol Cell Biochem 2017;426:27-45. [PMID: 27868170 DOI: 10.1007/s11010-016-2878-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 88] [Article Influence: 12.3] [Reference Citation Analysis]
197 Crescenzo R, Bianco F, Mazzoli A, Giacco A, Liverini G, Iossa S. A possible link between hepatic mitochondrial dysfunction and diet-induced insulin resistance. Eur J Nutr 2016;55:1-6. [PMID: 26476631 DOI: 10.1007/s00394-015-1073-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
198 Markgraf DF, Al-Hasani H, Lehr S. Lipidomics-Reshaping the Analysis and Perception of Type 2 Diabetes. Int J Mol Sci 2016;17:E1841. [PMID: 27827927 DOI: 10.3390/ijms17111841] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
199 Mostafa DK, Nasra RA, Zahran N, Ghoneim MT. Pleiotropic protective effects of Vitamin D against high fat diet-induced metabolic syndrome in rats: One for all. Eur J Pharmacol 2016;792:38-47. [PMID: 27789220 DOI: 10.1016/j.ejphar.2016.10.031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
200 Petersen MC, Madiraju AK, Gassaway BM, Marcel M, Nasiri AR, Butrico G, Marcucci MJ, Zhang D, Abulizi A, Zhang XM, Philbrick W, Hubbard SR, Jurczak MJ, Samuel VT, Rinehart J, Shulman GI. Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance. J Clin Invest 2016;126:4361-71. [PMID: 27760050 DOI: 10.1172/JCI86013] [Cited by in Crossref: 108] [Cited by in F6Publishing: 124] [Article Influence: 18.0] [Reference Citation Analysis]
201 Ozcan L, Tabas I. Calcium signalling and ER stress in insulin resistance and atherosclerosis. J Intern Med 2016;280:457-64. [PMID: 27739133 DOI: 10.1111/joim.12562] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
202 Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14:32-42. [PMID: 27729660 DOI: 10.1038/nrgastro.2016.147] [Cited by in Crossref: 445] [Cited by in F6Publishing: 414] [Article Influence: 74.2] [Reference Citation Analysis]
203 Lee DH, Han DH, Nam KT, Park JS, Kim SH, Lee M, Kim G, Min BS, Cha BS, Lee YS, Sung SH, Jeong H, Ji HW, Lee MJ, Lee JS, Lee HY, Chun Y, Kim J, Komatsu M, Lee YH, Bae SH. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis. Free Radic Biol Med 2016;99:520-32. [PMID: 27634173 DOI: 10.1016/j.freeradbiomed.2016.09.009] [Cited by in F6Publishing: 46] [Reference Citation Analysis]
204 Xia MF, Yki-Järvinen H, Bian H, Lin HD, Yan HM, Chang XX, Zhou Y, Gao X. Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease. PLoS One 2016;11:e0160526. [PMID: 27579785 DOI: 10.1371/journal.pone.0160526] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
205 Ahn B, Soundarapandian MM, Sessions H, Peddibhotla S, Roth GP, Li JL, Sugarman E, Koo A, Malany S, Wang M, Yea K, Brooks J, Leone TC, Han X, Vega RB, Kelly DP. MondoA coordinately regulates skeletal myocyte lipid homeostasis and insulin signaling. J Clin Invest 2016;126:3567-79. [PMID: 27500491 DOI: 10.1172/JCI87382] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
206 Shang J, Castro-Perez JM, Shen X, Zhu Y, Liu H, Qian Y, Previs S, Howard AD, Erion M, Kelley DE, Wang L. Duodenal-jejunal bypass surgery induces hepatic lipidomic alterations associated with ameliorated hepatic steatosis in mice. Obesity (Silver Spring) 2016;24:1938-45. [PMID: 27458076 DOI: 10.1002/oby.21583] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
207 Herman MA, Samuel VT. The Sweet Path to Metabolic Demise: Fructose and Lipid Synthesis. Trends Endocrinol Metab 2016;27:719-30. [PMID: 27387598 DOI: 10.1016/j.tem.2016.06.005] [Cited by in Crossref: 103] [Cited by in F6Publishing: 105] [Article Influence: 17.2] [Reference Citation Analysis]
208 Karahashi M, Hirata-Hanta Y, Kawabata K, Tsutsumi D, Kametani M, Takamatsu N, Sakamoto T, Yamazaki T, Asano S, Mitsumoto A, Kawashima Y, Kudo N. Abnormalities in the Metabolism of Fatty Acids and Triacylglycerols in the Liver of the Goto-Kakizaki Rat: A Model for Non-Obese Type 2 Diabetes. Lipids 2016;51:955-71. [PMID: 27372943 DOI: 10.1007/s11745-016-4171-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
209 Valenti L, Bugianesi E, Pajvani U, Targher G. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? Liver Int 2016;36:1563-79. [DOI: 10.1111/liv.13185] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 14.2] [Reference Citation Analysis]
210 Ertunc ME, Hotamisligil GS. Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment. J Lipid Res. 2016;57:2099-2114. [PMID: 27330055 DOI: 10.1194/jlr.r066514] [Cited by in Crossref: 209] [Cited by in F6Publishing: 223] [Article Influence: 34.8] [Reference Citation Analysis]
211 Liu C, Zhong R, Lou J, Pan A, Tang Y, Chang J, Ke J, Li J, Yuan J, Wang Y, Chen W, Guo H, Wei S, Liang Y, Zhang X, He M, Hu FB, Wu T, Yao P, Miao X. Nighttime sleep duration and risk of nonalcoholic fatty liver disease: the Dongfeng-Tongji prospective study. Ann Med 2016;48:468-76. [PMID: 27327959 DOI: 10.1080/07853890.2016.1193787] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
212 Herrema H, Zhou Y, Zhang D, Lee J, Salazar Hernandez MA, Shulman GI, Ozcan U. XBP1s Is an Anti-lipogenic Protein. J Biol Chem 2016;291:17394-404. [PMID: 27325692 DOI: 10.1074/jbc.M116.728949] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 7.2] [Reference Citation Analysis]
213 Yilmaz M, Claiborn KC, Hotamisligil GS. De Novo Lipogenesis Products and Endogenous Lipokines. Diabetes 2016;65:1800-7. [PMID: 27288005 DOI: 10.2337/db16-0251] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.8] [Reference Citation Analysis]
214 Ozcan L, Ghorpade DS, Zheng Z, de Souza JC, Chen K, Bessler M, Bagloo M, Schrope B, Pestell R, Tabas I. Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance. Cell Rep 2016;15:2214-25. [PMID: 27239042 DOI: 10.1016/j.celrep.2016.05.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
215 Wang L, Zhang B, Huang F, Liu B, Xie Y. Curcumin inhibits lipolysis via suppression of ER stress in adipose tissue and prevents hepatic insulin resistance. J Lipid Res 2016;57:1243-55. [PMID: 27220352 DOI: 10.1194/jlr.M067397] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 7.2] [Reference Citation Analysis]
216 Summers SA. The ART of Lowering Ceramides. Cell Metab 2015;22:195-6. [PMID: 26244926 DOI: 10.1016/j.cmet.2015.07.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
217 Seo NK, Koo HS, Haam JH, Kim HY, Kim MJ, Park KC, Park KS, Kim YS. Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone. J Gastroenterol Hepatol 2015;30:1211-6. [PMID: 25708291 DOI: 10.1111/jgh.12935] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
218 Han X, Liu C, Xue Y, Wang J, Xue C, Yanagita T, Gao X, Wang Y. Long-term fatty liver-induced insulin resistance in orotic acid-induced nonalcoholic fatty liver rats. Bioscience, Biotechnology, and Biochemistry 2016;80:735-43. [DOI: 10.1080/09168451.2015.1123608] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
219 Kwon H, Song K, Han C, Chen W, Wang Y, Dash S, Lim K, Wu T. Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease. Hepatology 2016;63:1155-69. [PMID: 26473743 DOI: 10.1002/hep.28289] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 9.5] [Reference Citation Analysis]
220 Wainwright P, Byrne CD. Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. Int J Mol Sci. 2016;17:367. [PMID: 26978356 DOI: 10.3390/ijms17030367] [Cited by in Crossref: 57] [Cited by in F6Publishing: 68] [Article Influence: 9.5] [Reference Citation Analysis]
221 Lassailly G, Caiazzo R, Pattou F, Mathurin P. Perspectives on Treatment for Nonalcoholic Steatohepatitis. Gastroenterology. 2016;150:1835-1848. [PMID: 26971824 DOI: 10.1053/j.gastro.2016.03.004] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 8.5] [Reference Citation Analysis]
222 Ballestri S, Nascimbeni F, Romagnoli D, Baldelli E, Targher G, Lonardo A. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight. Int J Mol Sci. 2016;17:355. [PMID: 27005620 DOI: 10.3390/ijms17030355] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
223 Leung PS. The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. Nutrients 2016;8:147. [PMID: 26959059 DOI: 10.3390/nu8030147] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 11.0] [Reference Citation Analysis]
224 Wang Z, Xu M, Hu Z, Shrestha UK. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause. 2015;22:667-673. [PMID: 25513983 DOI: 10.1097/gme.0000000000000352] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
225 Williams KJ, Wu X. Imbalanced insulin action in chronic over nutrition: Clinical harm, molecular mechanisms, and a way forward. Atherosclerosis 2016;247:225-82. [PMID: 26967715 DOI: 10.1016/j.atherosclerosis.2016.02.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
226 Deminice R, de Castro GS, Brosnan ME, Brosnan JT. Creatine supplementation as a possible new therapeutic approach for fatty liver disease: early findings. Amino Acids 2016;48:1983-91. [PMID: 26832170 DOI: 10.1007/s00726-016-2183-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
227 Ress C, Kaser S. Mechanisms of intrahepatic triglyceride accumulation. World J Gastroenterol 2016; 22(4): 1664-1673 [PMID: 26819531 DOI: 10.3748/wjg.v22.i4.1664] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
228 Luukkonen PK, Zhou Y, Sädevirta S, Leivonen M, Arola J, Orešič M, Hyötyläinen T, Yki-Järvinen H. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease. J Hepatol 2016;64:1167-75. [PMID: 26780287 DOI: 10.1016/j.jhep.2016.01.002] [Cited by in Crossref: 208] [Cited by in F6Publishing: 234] [Article Influence: 34.7] [Reference Citation Analysis]
229 Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126:12-22. [PMID: 26727229 DOI: 10.1172/jci77812] [Cited by in Crossref: 540] [Cited by in F6Publishing: 589] [Article Influence: 90.0] [Reference Citation Analysis]
230 Kirchner H, Sinha I, Gao H, Ruby MA, Schönke M, Lindvall JM, Barrès R, Krook A, Näslund E, Dahlman-Wright K, Zierath JR. Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients. Mol Metab 2016;5:171-83. [PMID: 26977391 DOI: 10.1016/j.molmet.2015.12.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 11.2] [Reference Citation Analysis]
231 Cho NH, Oh TJ, Kim KM, Choi SH, Lee JH, Park KS, Jang HC, Kim JY, Lee HK, Lim S. Neck Circumference and Incidence of Diabetes Mellitus over 10 Years in the Korean Genome and Epidemiology Study (KoGES). Sci Rep 2015;5:18565. [PMID: 26681338 DOI: 10.1038/srep18565] [Cited by in Crossref: 16] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
232 Ioannou GN. The Role of Cholesterol in the Pathogenesis of NASH. Trends Endocrinol Metab. 2016;27:84-95. [PMID: 26703097 DOI: 10.1016/j.tem.2015.11.008] [Cited by in Crossref: 180] [Cited by in F6Publishing: 233] [Article Influence: 25.7] [Reference Citation Analysis]
233 Rieusset J, Fauconnier J, Paillard M, Belaidi E, Tubbs E, Chauvin MA, Durand A, Bravard A, Teixeira G, Bartosch B, Michelet M, Theurey P, Vial G, Demion M, Blond E, Zoulim F, Gomez L, Vidal H, Lacampagne A, Ovize M. Disruption of calcium transfer from ER to mitochondria links alterations of mitochondria-associated ER membrane integrity to hepatic insulin resistance. Diabetologia 2016;59:614-23. [PMID: 26660890 DOI: 10.1007/s00125-015-3829-8] [Cited by in Crossref: 77] [Cited by in F6Publishing: 74] [Article Influence: 11.0] [Reference Citation Analysis]
234 Popov VB, Jornayvaz FR, Akgul EO, Kanda S, Jurczak MJ, Zhang D, Abudukadier A, Majumdar SK, Guigni B, Petersen KF. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance. FASEB J. 2016;30:1207-1217. [PMID: 26644352 DOI: 10.1096/fj.15-271999] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
235 Asrih M, Jornayvaz FR. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? Molecular and Cellular Endocrinology 2015;418:55-65. [DOI: 10.1016/j.mce.2015.02.018] [Cited by in Crossref: 150] [Cited by in F6Publishing: 174] [Article Influence: 21.4] [Reference Citation Analysis]
236 Morigny P, Houssier M, Mouisel E, Langin D. Adipocyte lipolysis and insulin resistance. Biochimie. 2016;125:259-266. [PMID: 26542285 DOI: 10.1016/j.biochi.2015.10.024] [Cited by in Crossref: 186] [Cited by in F6Publishing: 212] [Article Influence: 26.6] [Reference Citation Analysis]
237 Vatner DF, Snikeris J, Popov V, Perry RJ, Rahimi Y, Samuel VT. 3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats. PLoS One 2015;10:e0140837. [PMID: 26485433 DOI: 10.1371/journal.pone.0140837] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
238 Ryu S, Chang Y, Jung HS, Yun KE, Kwon MJ, Choi Y, Kim CW, Cho J, Suh BS, Cho YK, Chung EC, Shin H, Kim YS. Relationship of sitting time and physical activity with non-alcoholic fatty liver disease. J Hepatol. 2015;63:1229-1237. [PMID: 26385766 DOI: 10.1016/j.jhep.2015.07.010] [Cited by in Crossref: 96] [Cited by in F6Publishing: 114] [Article Influence: 13.7] [Reference Citation Analysis]
239 Kung DW, Griffith DA, Esler WP, Vajdos FF, Mathiowetz AM, Doran SD, Amor PA, Bagley SW, Banks T, Cabral S, Ford K, Garcia-Irizarry CN, Landis MS, Loomis K, McPherson K, Niosi M, Rockwell KL, Rose C, Smith AC, Southers JA, Tapley S, Tu M, Valentine JJ. Discovery of spirocyclic-diamine inhibitors of mammalian acetyl CoA-carboxylase. Bioorg Med Chem Lett 2015;25:5352-6. [PMID: 26411795 DOI: 10.1016/j.bmcl.2015.09.035] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
240 Kim JA, Jang HJ, Hwang DH. Toll-like receptor 4-induced endoplasmic reticulum stress contributes to impairment of vasodilator action of insulin. Am J Physiol Endocrinol Metab 2015;309:E767-76. [PMID: 26522062 DOI: 10.1152/ajpendo.00369.2015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
241 Camporez JPG, Asrih M, Zhang D, Kahn M, Samuel VT, Jurczak MJ, Jornayvaz FR. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21. Journal of Endocrinology 2015;226:207-17. [DOI: 10.1530/joe-15-0136] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
242 Xia M, Bian H, Yan H, Lin H, Chang X, Li X, Ma H, He W, Zhao N, Xia P, Gao X. Assessment of liver fat content using quantitative ultrasonography to evaluate risks for metabolic diseases: Liver Fat Content and Metabolic Diseases. Obesity 2015;23:1929-37. [DOI: 10.1002/oby.21182] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
243 Declèves AE, Sharma K. Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Curr Opin Nephrol Hypertens 2015;24:28-36. [PMID: 25470014 DOI: 10.1097/MNH.0000000000000087] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 6.6] [Reference Citation Analysis]
244 Finck BN, Hall AM. Does Diacylglycerol Accumulation in Fatty Liver Disease Cause Hepatic Insulin Resistance? Biomed Res Int 2015;2015:104132. [PMID: 26273583 DOI: 10.1155/2015/104132] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
245 Eichmann TO, Lass A. DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signaling. Cell Mol Life Sci 2015;72:3931-52. [PMID: 26153463 DOI: 10.1007/s00018-015-1982-3] [Cited by in Crossref: 80] [Cited by in F6Publishing: 104] [Article Influence: 11.4] [Reference Citation Analysis]
246 Fabbrini E, Magkos F. Hepatic Steatosis as a Marker of Metabolic Dysfunction. Nutrients 2015;7:4995-5019. [PMID: 26102213 DOI: 10.3390/nu7064995] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 12.9] [Reference Citation Analysis]
247 Berlanga A, Guiu-Jurado E, Porras JA, Aragonès G, Auguet T. [Role of metabolic lipases and lipotoxicity in the development of non-alcoholic steatosis and non-alcoholic steatohepatitis]. Clin Investig Arterioscler 2016;28:47-61. [PMID: 26049666 DOI: 10.1016/j.arteri.2015.03.003] [Reference Citation Analysis]
248 Akie TE, Liu L, Nam M, Lei S, Cooper MP. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease. PLoS One 2015;10:e0125617. [PMID: 25933096 DOI: 10.1371/journal.pone.0125617] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
249 Jiang ZG, Tsugawa Y, Tapper EB, Lai M, Afdhal N, Robson SC, Mukamal KJ. Low-fasting triglyceride levels are associated with non-invasive markers of advanced liver fibrosis among adults in the United States. Aliment Pharmacol Ther 2015;42:106-16. [DOI: 10.1111/apt.13216] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
250 Chan SM, Zeng XY, Sun RQ, Jo E, Zhou X, Wang H, Li S, Xu A, Watt MJ, Ye JM. Fenofibrate insulates diacylglycerol in lipid droplet/ER and preserves insulin signaling transduction in the liver of high fat fed mice. Biochim Biophys Acta 2015;1852:1511-9. [PMID: 25906681 DOI: 10.1016/j.bbadis.2015.04.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
251 Joshi S, Liu M, Turner N. Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime. Biomed Res Int 2015;2015:390863. [PMID: 25961014 DOI: 10.1155/2015/390863] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
252 Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Digestive and Liver Disease 2015;47:181-90. [DOI: 10.1016/j.dld.2014.09.020] [Cited by in Crossref: 443] [Cited by in F6Publishing: 409] [Article Influence: 63.3] [Reference Citation Analysis]
253 Shomonov-Wagner L, Raz A, Leikin-Frenkel A. Alpha linolenic acid in maternal diet halts the lipid disarray due to saturated fatty acids in the liver of mice offspring at weaning. Lipids Health Dis 2015;14:14. [PMID: 25889505 DOI: 10.1186/s12944-015-0012-7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
254 Li P, Oh DY, Bandyopadhyay G, Lagakos WS, Talukdar S, Osborn O, Johnson A, Chung H, Maris M, Ofrecio JM, Taguchi S, Lu M, Olefsky JM. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat Med 2015;21:239-47. [PMID: 25706874 DOI: 10.1038/nm.3800] [Cited by in Crossref: 164] [Cited by in F6Publishing: 186] [Article Influence: 23.4] [Reference Citation Analysis]
255 Perry RJ, Camporez JG, Kursawe R, Titchenell PM, Zhang D, Perry CJ, Jurczak MJ, Abudukadier A, Han MS, Zhang XM, Ruan HB, Yang X, Caprio S, Kaech SM, Sul HS, Birnbaum MJ, Davis RJ, Cline GW, Petersen KF, Shulman GI. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160:745-758. [PMID: 25662011 DOI: 10.1016/j.cell.2015.01.012] [Cited by in Crossref: 376] [Cited by in F6Publishing: 389] [Article Influence: 53.7] [Reference Citation Analysis]
256 Liu M, Xu L, Yin L, Qi Y, Xu Y, Han X, Zhao Y, Sun H, Yao J, Lin Y. Potent effects of dioscin against obesity in mice. Sci Rep. 2015;5:7973. [PMID: 25609476 DOI: 10.1038/srep07973] [Cited by in Crossref: 51] [Cited by in F6Publishing: 59] [Article Influence: 7.3] [Reference Citation Analysis]
257 Aroor AR, Habibi J, Ford DA, Nistala R, Lastra G, Manrique C, Dunham MM, Ford KD, Thyfault JP, Parks EJ. Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function. Diabetes. 2015;64:1988-2001. [PMID: 25605806 DOI: 10.2337/db14-0804] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
258 Zhang X, Wang S, Li Y, Zhao D, An N, Wu J, Zhang T, Wu C, Li Y. Tadehaginoside modulates lipogenesis and glucose consumption in HepG2 cells. Natural Product Research 2015;29:2287-90. [DOI: 10.1080/14786419.2014.1001387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
259 Lu W, Cheng YC, Chen K, Wang H, Gerhard GS, Still CD, Chu X, Yang R, Parihar A, O'Connell JR, Pollin TI, Angles-Cano E, Quon MJ, Mitchell BD, Shuldiner AR, Fu M. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. Hum Mol Genet 2015;24:2390-400. [PMID: 25575512 DOI: 10.1093/hmg/ddu731] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
260 McFadden JW, Aja S, Li Q, Bandaru VV, Kim EK, Haughey NJ, Kuhajda FP, Ronnett GV. Increasing fatty acid oxidation remodels the hypothalamic neurometabolome to mitigate stress and inflammation. PLoS One 2014;9:e115642. [PMID: 25541737 DOI: 10.1371/journal.pone.0115642] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
261 Gerhard GS, Benotti P, Wood GC, Chu X, Argyropoulos G, Petrick A, Strodel WE, Gabrielsen JD, Ibele A, Still CD, Kingsley C, DiStefano J. Identification of novel clinical factors associated with hepatic fat accumulation in extreme obesity. J Obes 2014;2014:368210. [PMID: 25610640 DOI: 10.1155/2014/368210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
262 Hartler J, Köfeler HC, Trötzmüller M, Thallinger GG, Spener F. Assessment of lipidomic species in hepatocyte lipid droplets from stressed mouse models. Sci Data 2014;1:140051. [PMID: 25977802 DOI: 10.1038/sdata.2014.51] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
263 Ryu S, Chang Y, Choi Y, Kwon MJ, Kim CW, Yun KE, Jung HS, Kim BK, Kim YJ, Ahn J, Cho YK, Kim KH, Chung EC, Shin H, Cho J. Age at menarche and non-alcoholic fatty liver disease. J Hepatol 2015;62:1164-70. [PMID: 25500721 DOI: 10.1016/j.jhep.2014.11.041] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
264 Kahle M, Schäfer A, Seelig A, Schultheiß J, Wu M, Aichler M, Leonhardt J, Rathkolb B, Rozman J, Sarioglu H, Hauck SM, Ueffing M, Wolf E, Kastenmueller G, Adamski J, Walch A, Hrabé de Angelis M, Neschen S. High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in mice. Mol Metab 2015;4:39-50. [PMID: 25685688 DOI: 10.1016/j.molmet.2014.11.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
265 Wang BF, Wang Y, Ao R, Tong J, Wang BY. AdipoQ T45 G and G276 T Polymorphisms and Susceptibility to Nonalcoholic Fatty Liver Disease Among Asian Populations: A Meta-Analysis and Meta-Regression. J Clin Lab Anal 2016;30:47-57. [PMID: 25385252 DOI: 10.1002/jcla.21814] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
266 Wang DQ, Portincasa P, Neuschwander-Tetri BA. Steatosis in the liver. Compr Physiol 2013;3:1493-532. [PMID: 24265237 DOI: 10.1002/cphy.c130001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
267 Fuchs CD, Claudel T, Trauner M. Role of metabolic lipases and lipolytic metabolites in the pathogenesis of NAFLD. Trends Endocrinol Metab 2014;25:576-85. [PMID: 25183341 DOI: 10.1016/j.tem.2014.08.001] [Cited by in Crossref: 41] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
268 Rabinowich L, Fishman S, Hubel E, Thurm T, Park WJ, Pewzner-Jung Y, Saroha A, Erez N, Halpern Z, Futerman AH, Zvibel I. Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity. J Hepatol 2015;62:175-81. [PMID: 25173968 DOI: 10.1016/j.jhep.2014.08.030] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
269 Wolf P, Winhofer Y, Anderwald C, Krššák M, Krebs M. Intracellular lipid accumulation and shift during diabetes progression. Wien Med Wochenschr 2014;164:320-9. [DOI: 10.1007/s10354-014-0292-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
270 Perry RJ, Samuel VT, Petersen KF, Shulman GI. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature. 2014;510:84-91. [PMID: 24899308 DOI: 10.1038/nature13478] [Cited by in Crossref: 621] [Cited by in F6Publishing: 677] [Article Influence: 77.6] [Reference Citation Analysis]
271 Chen X, Fu XS, Li CP, Zhao HX. ER stress and ER stress-induced apoptosis are activated in gastric SMCs in diabetic rats. World J Gastroenterol 2014; 20(25): 8260-8267 [PMID: 25009401 DOI: 10.3748/wjg.v20.i25.8260] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
272 Heinonen I, Rinne P, Ruohonen ST, Ruohonen S, Ahotupa M, Savontaus E. The effects of equal caloric high fat and western diet on metabolic syndrome, oxidative stress and vascular endothelial function in mice. Acta Physiol (Oxf) 2014;211:515-27. [PMID: 24621461 DOI: 10.1111/apha.12253] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
273 Wu Z, Liu D, Proksch P, Guo P, Lin W. Punctaporonins H-M: caryophyllene-type sesquiterpenoids from the sponge-associated fungus Hansfordia sinuosae. Mar Drugs 2014;12:3904-16. [PMID: 24983636 DOI: 10.3390/md12073904] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
274 Koppe SW. Obesity and the liver: nonalcoholic fatty liver disease. Transl Res. 2014;164:312-322. [PMID: 25028077 DOI: 10.1016/j.trsl.2014.06.008] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
275 Legry V, Van Rooyen D, Lambert B, Sempoux C, Poekes L, Español-suñer R, Molendi-coste O, Horsmans Y, Farrell G, Leclercq I. Endoplasmic reticulum stress does not contribute to steatohepatitis in obese and insulin-resistant high-fat-diet-fed foz/foz mice. Clinical Science 2014;127:507-18. [DOI: 10.1042/cs20140026] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
276 Szendroedi J, Yoshimura T, Phielix E, Koliaki C, Marcucci M, Zhang D, Jelenik T, Müller J, Herder C, Nowotny P, Shulman GI, Roden M. Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans. Proc Natl Acad Sci U S A 2014;111:9597-602. [PMID: 24979806 DOI: 10.1073/pnas.1409229111] [Cited by in Crossref: 237] [Cited by in F6Publishing: 229] [Article Influence: 29.6] [Reference Citation Analysis]
277 Hage Hassan R, Bourron O, Hajduch E. Defect of insulin signal in peripheral tissues: Important role of ceramide. World J Diabetes 2014; 5(3): 244-257 [PMID: 24936246 DOI: 10.4239/wjd.v5.i3.244] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 46] [Article Influence: 6.6] [Reference Citation Analysis]
278 Tkachuk VA, Vorotnikov AV. Molecular Mechanisms of Insulin Resistance Development. Diabetes mellitus 2014;17:29-40. [DOI: 10.14341/dm2014229-40] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
279 Byrne CD, Targher G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler Thromb Vasc Biol. 2014;34:1155-1161. [PMID: 24743428 DOI: 10.1161/atvbaha.114.303034] [Cited by in Crossref: 96] [Cited by in F6Publishing: 93] [Article Influence: 12.0] [Reference Citation Analysis]
280 Fisher E, Lake E, McLeod RS. Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion. J Biomed Res 2014;28:178-93. [PMID: 25013401 DOI: 10.7555/JBR.28.20140019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 19] [Article Influence: 0.4] [Reference Citation Analysis]
281 Bartels ED, Ploug T, Størling J, Mandrup-poulsen T, Nielsen LB. Skeletal muscle apolipoprotein B expression reduces muscular triglyceride accumulation. Scandinavian Journal of Clinical and Laboratory Investigation 2014;74:351-7. [DOI: 10.3109/00365513.2014.893446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
282 Sahini N, Borlak J. Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes. Prog Lipid Res. 2014;54:86-112. [PMID: 24607340 DOI: 10.1016/j.plipres.2014.02.002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 7.9] [Reference Citation Analysis]
283 Hall AM, Soufi N, Chambers KT, Chen Z, Schweitzer GG, McCommis KS, Erion DM, Graham MJ, Su X, Finck BN. Abrogating monoacylglycerol acyltransferase activity in liver improves glucose tolerance and hepatic insulin signaling in obese mice. Diabetes 2014;63:2284-96. [PMID: 24595352 DOI: 10.2337/db13-1502] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.9] [Reference Citation Analysis]
284 Ferramosca A, Zara V. Modulation of hepatic steatosis by dietary fatty acids. World J Gastroenterol 2014; 20(7): 1746-1755 [PMID: 24587652 DOI: 10.3748/wjg.v20.i7.1746] [Cited by in CrossRef: 113] [Cited by in F6Publishing: 105] [Article Influence: 14.1] [Reference Citation Analysis]
285 Zhang XQ, Xu CF, Yu CH, Chen WX, Li YM. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(7): 1768-1776 [PMID: 24587654 DOI: 10.3748/wjg.v20.i7.1768] [Cited by in CrossRef: 176] [Cited by in F6Publishing: 163] [Article Influence: 22.0] [Reference Citation Analysis]
286 Kim SK, Choi YJ, Huh BW, Park SW, Lee EJ, Cho YW, Huh KB. Nonalcoholic Fatty liver disease is associated with increased carotid intima-media thickness only in type 2 diabetic subjects with insulin resistance. J Clin Endocrinol Metab 2014;99:1879-84. [PMID: 24512497 DOI: 10.1210/jc.2013-4133] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
287 Birkenfeld AL, Shulman GI. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes. Hepatology 2014;59:713-23. [PMID: 23929732 DOI: 10.1002/hep.26672] [Cited by in Crossref: 429] [Cited by in F6Publishing: 410] [Article Influence: 53.6] [Reference Citation Analysis]
288 Galbo T, Shulman GI. Lipid-induced hepatic insulin resistance. Aging (Albany NY) 2013;5:582-3. [PMID: 23929893 DOI: 10.18632/aging.100585] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
289 Guo S. Insulin signaling, resistance, and the metabolic syndrome: insights from mouse models into disease mechanisms. J Endocrinol 2014;220:T1-T23. [PMID: 24281010 DOI: 10.1530/JOE-13-0327] [Cited by in Crossref: 208] [Cited by in F6Publishing: 278] [Article Influence: 26.0] [Reference Citation Analysis]
290 Loria P, Marchesini G, Nascimbeni F, Ballestri S, Maurantonio M, Carubbi F, Ratziu V, Lonardo A. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis 2014;232:99-109. [DOI: 10.1016/j.atherosclerosis.2013.10.030] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 9.8] [Reference Citation Analysis]
291 Koh HJ, Toyoda T, Didesch MM, Lee MY, Sleeman MW, Kulkarni RN, Musi N, Hirshman MF, Goodyear LJ. Tribbles 3 mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle. Nat Commun 2013;4:1871. [PMID: 23695665 DOI: 10.1038/ncomms2851] [Cited by in Crossref: 66] [Cited by in F6Publishing: 68] [Article Influence: 7.3] [Reference Citation Analysis]
292 Wu C, Luan H, Wang S, Zhang X, Wang R, Jin L, Guo P, Chen X. Modulation of lipogenesis and glucose consumption in HepG2 cells and C2C12 myotubes by sophoricoside. Molecules 2013;18:15624-35. [PMID: 24352018 DOI: 10.3390/molecules181215624] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
293 Hecht L, Weiss R. Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Obese Children. Curr Diab Rep 2014;14. [DOI: 10.1007/s11892-013-0448-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
294 Fruci B, Giuliano S, Mazza A, Malaguarnera R, Belfiore A. Nonalcoholic Fatty liver: a possible new target for type 2 diabetes prevention and treatment. Int J Mol Sci. 2013;14:22933-22966. [PMID: 24264040 DOI: 10.3390/ijms141122933] [Cited by in Crossref: 62] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
295 Greene MW, Burrington CM, Luo Y, Ruhoff MS, Lynch DT, Chaithongdi N. PKCδ is activated in the liver of obese Zucker rats and mediates diet-induced whole body insulin resistance and hepatocyte cellular insulin resistance. J Nutr Biochem 2014;25:281-8. [PMID: 24524901 DOI: 10.1016/j.jnutbio.2013.10.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
296 do Nascimento JH, Epifanio M, Soder RB, Baldisserotto M. MRI-diagnosed nonalcoholic fatty liver disease is correlated to insulin resistance in adolescents. Acad Radiol 2013;20:1436-42. [PMID: 24119357 DOI: 10.1016/j.acra.2013.08.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
297 Close AF, Rouillard C, Buteau J. NR4A orphan nuclear receptors in glucose homeostasis: a minireview. Diabetes Metab 2013;39:478-84. [PMID: 24075454 DOI: 10.1016/j.diabet.2013.07.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
298 Taylor R. Type 2 diabetes: etiology and reversibility. Diabetes Care. 2013;36:1047-1055. [PMID: 23520370 DOI: 10.2337/dc12-1805] [Cited by in Crossref: 209] [Cited by in F6Publishing: 169] [Article Influence: 23.2] [Reference Citation Analysis]
299 Schleicher J, Guthke R, Dahmen U, Dirsch O, Holzhuetter HG, Schuster S. A theoretical study of lipid accumulation in the liver-implications for nonalcoholic fatty liver disease. Biochim Biophys Acta 2014;1841:62-9. [PMID: 23999488 DOI: 10.1016/j.bbalip.2013.08.016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
300 Wang Y, Zhang Y, Qian H, Lu J, Zhang Z, Min X, Lang M, Yang H, Wang N, Zhang P. The g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism. PLoS One. 2013;8:e72315. [PMID: 23951308 DOI: 10.1371/journal.pone.0072315] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
301 Montesi L, Mazzotti A, Moscatiello S, Forlani G, Marchesini G. Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH. Hepatol Int 2013;7:814-22. [DOI: 10.1007/s12072-013-9451-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
302 Heilbronn LK, Coster AC, Campbell LV, Greenfield JR, Lange K, Christopher MJ, Meikle PJ, Samocha-Bonet D. The effect of short-term overfeeding on serum lipids in healthy humans. Obesity (Silver Spring) 2013;21:E649-59. [PMID: 23640727 DOI: 10.1002/oby.20508] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.2] [Reference Citation Analysis]
303 Guebre-Egziabher F, Alix PM, Koppe L, Pelletier CC, Kalbacher E, Fouque D, Soulage CO. Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie 2013;95:1971-9. [PMID: 23896376 DOI: 10.1016/j.biochi.2013.07.017] [Cited by in Crossref: 77] [Cited by in F6Publishing: 84] [Article Influence: 8.6] [Reference Citation Analysis]
304 Galbo T, Perry RJ, Jurczak MJ, Camporez JP, Alves TC, Kahn M, Guigni BA, Serr J, Zhang D, Bhanot S, Samuel VT, Shulman GI. Saturated and unsaturated fat induce hepatic insulin resistance independently of TLR-4 signaling and ceramide synthesis in vivo. Proc Natl Acad Sci U S A 2013;110:12780-5. [PMID: 23840067 DOI: 10.1073/pnas.1311176110] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
305 Loria P, Lonardo A, Anania F. Liver and diabetes. A vicious circle. Hepatol Res 2013;43:51-64. [PMID: 23332087 DOI: 10.1111/j.1872-034X.2012.01031.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 125] [Article Influence: 12.7] [Reference Citation Analysis]
306 Koliaki C, Roden M. Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. Mol Cell Endocrinol. 2013;379:35-42. [PMID: 23770462 DOI: 10.1016/j.mce.2013.06.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
307 Chitraju C, Trötzmüller M, Hartler J, Wolinski H, Thallinger GG, Haemmerle G, Zechner R, Zimmermann R, Köfeler HC, Spener F. The impact of genetic stress by ATGL deficiency on the lipidome of lipid droplets from murine hepatocytes. J Lipid Res. 2013;54:2185-2194. [PMID: 23740967 DOI: 10.1194/jlr.m037952] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
308 Rector RS, Morris EM, Ridenhour S, Meers GM, Hsu FF, Turk J, Ibdah JA. Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology 2013;57:2213-23. [PMID: 23359250 DOI: 10.1002/hep.26285] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
309 Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-Campoy JM, Jones SR, Kumar R, La Forge R. Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association. J Clin Lipidol. 2013;7:304-383. [PMID: 23890517 DOI: 10.1016/j.jacl.2013.04.001] [Cited by in Crossref: 199] [Cited by in F6Publishing: 217] [Article Influence: 22.1] [Reference Citation Analysis]
310 Chu MP, Klopfenstein BJ, Krisky CM, Urbanski HF, Rooney WD, Kohama SG, Purnell JQ. Intrahepatic lipid, not visceral or muscle fat, is correlated with insulin resistance in older, female rhesus macaques. Obesity (Silver Spring) 2013;21:2021-8. [PMID: 23408675 DOI: 10.1002/oby.20339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
311 Zhang S, Zheng L, Dong D, Xu L, Yin L, Qi Y, Han X, Lin Y, Liu K, Peng J. Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem. 2013;141:2108-2116. [PMID: 23870935 DOI: 10.1016/j.foodchem.2013.05.019] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 7.3] [Reference Citation Analysis]
312 Zelber-sagi S, Lotan R, Shibolet O, Webb M, Buch A, Nitzan-kaluski D, Halpern Z, Santo E, Oren R. Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. Liver Int 2013;33:1406-12. [DOI: 10.1111/liv.12200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
313 Vatner DF, Weismann D, Beddow SA, Kumashiro N, Erion DM, Liao XH, Grover GJ, Webb P, Phillips KJ, Weiss RE, Bogan JS, Baxter J, Shulman GI, Samuel VT. Thyroid hormone receptor-β agonists prevent hepatic steatosis in fat-fed rats but impair insulin sensitivity via discrete pathways. Am J Physiol Endocrinol Metab 2013;305:E89-100. [PMID: 23651850 DOI: 10.1152/ajpendo.00573.2012] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 6.7] [Reference Citation Analysis]
314 Schmitz-Peiffer C. The tail wagging the dog--regulation of lipid metabolism by protein kinase C. FEBS J. 2013;280:5371-5383. [PMID: 23587021 DOI: 10.1111/febs.12285] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
315 Kumashiro N, Yoshimura T, Cantley JL, Majumdar SK, Guebre-Egziabher F, Kursawe R, Vatner DF, Fat I, Kahn M, Erion DM, Zhang XM, Zhang D, Manchem VP, Bhanot S, Gerhard GS, Petersen KF, Cline GW, Samuel VT, Shulman GI. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats. Hepatology 2013;57:1763-72. [PMID: 23175050 DOI: 10.1002/hep.26170] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 7.1] [Reference Citation Analysis]
316 Kim CW, Yun KE, Jung HS, Chang Y, Choi ES, Kwon MJ, Lee EH, Woo EJ, Kim NH, Shin H. Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses. J Hepatol. 2013;59:351-357. [PMID: 23578884 DOI: 10.1016/j.jhep.2013.03.035] [Cited by in Crossref: 81] [Cited by in F6Publishing: 99] [Article Influence: 9.0] [Reference Citation Analysis]
317 Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev. 2013;34:463-500. [PMID: 23550081 DOI: 10.1210/er.2012-1041] [Cited by in Crossref: 133] [Cited by in F6Publishing: 142] [Article Influence: 14.8] [Reference Citation Analysis]
318 Jiang P, Huang Z, Zhao H, Wei T. Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease. Biochem Biophys Res Commun. 2013;433:408-414. [PMID: 23537653 DOI: 10.1016/j.bbrc.2013.02.118] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
319 Goodarzi MO, Guo X, Cui J, Jones MR, Haritunians T, Xiang AH, Chen YD, Taylor KD, Buchanan TA, Hsueh WA, Raffel LJ, Rotter JI. Systematic evaluation of validated type 2 diabetes and glycaemic trait loci for association with insulin clearance. Diabetologia 2013;56:1282-90. [PMID: 23494448 DOI: 10.1007/s00125-013-2880-6] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
320 Nowotny B, Zahiragic L, Krog D, Nowotny PJ, Herder C, Carstensen M, Yoshimura T, Szendroedi J, Phielix E, Schadewaldt P, Schloot NC, Shulman GI, Roden M. Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans. Diabetes 2013;62:2240-8. [PMID: 23454694 DOI: 10.2337/db12-1179] [Cited by in Crossref: 74] [Cited by in F6Publishing: 74] [Article Influence: 8.2] [Reference Citation Analysis]
321 Karlas T, Wiegand J, Berg T. Gastrointestinal complications of obesity: non-alcoholic fatty liver disease (NAFLD) and its sequelae. Best Pract Res Clin Endocrinol Metab. 2013;27:195-208. [PMID: 23731881 DOI: 10.1016/j.beem.2013.02.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 5.4] [Reference Citation Analysis]
322 Suzuki M, Iio Y, Saito N, Fujimoto T. Protein kinase Cη is targeted to lipid droplets. Histochem Cell Biol 2013;139:505-11. [PMID: 23436195 DOI: 10.1007/s00418-013-1083-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
323 Kumashiro N, Beddow SA, Vatner DF, Majumdar SK, Cantley JL, Guebre-Egziabher F, Fat I, Guigni B, Jurczak MJ, Birkenfeld AL, Kahn M, Perler BK, Puchowicz MA, Manchem VP, Bhanot S, Still CD, Gerhard GS, Petersen KF, Cline GW, Shulman GI, Samuel VT. Targeting pyruvate carboxylase reduces gluconeogenesis and adiposity and improves insulin resistance. Diabetes 2013;62:2183-94. [PMID: 23423574 DOI: 10.2337/db12-1311] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 8.3] [Reference Citation Analysis]
324 Lu C, Liu X, Ding X, Chen X, Fan H, Liu Y, Xie N, Tan Y, Ko J, Zhang W, Lu A. A Metabolomics Profiling Study in Hand-Foot-and-Mouth Disease and Modulated Pathways of Clinical Intervention Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry. Evid Based Complement Alternat Med 2013;2013:647452. [PMID: 23533509 DOI: 10.1155/2013/647452] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
325 Lind KR, Ball KK, Cruz NF, Dienel GA. The unfolded protein response to endoplasmic reticulum stress in cultured astrocytes and rat brain during experimental diabetes. Neurochem Int 2013;62:784-95. [PMID: 23411409 DOI: 10.1016/j.neuint.2013.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
326 Cantley JL, Yoshimura T, Camporez JP, Zhang D, Jornayvaz FR, Kumashiro N, Guebre-Egziabher F, Jurczak MJ, Kahn M, Guigni BA, Serr J, Hankin J, Murphy RC, Cline GW, Bhanot S, Manchem VP, Brown JM, Samuel VT, Shulman GI. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance. Proc Natl Acad Sci U S A 2013;110:1869-74. [PMID: 23302688 DOI: 10.1073/pnas.1219456110] [Cited by in Crossref: 112] [Cited by in F6Publishing: 112] [Article Influence: 12.4] [Reference Citation Analysis]
327 Savard C, Tartaglione EV, Kuver R, Haigh WG, Farrell GC, Subramanian S, Chait A, Yeh MM, Quinn LS, Ioannou GN. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 2013;57:81-92. [PMID: 22508243 DOI: 10.1002/hep.25789] [Cited by in Crossref: 169] [Cited by in F6Publishing: 164] [Article Influence: 18.8] [Reference Citation Analysis]
328 Puppala J, Siddapuram SP, Akka J, Munshi A. Genetics of nonalcoholic Fatty liver disease: an overview. J Genet Genomics. 2013;40:15-22. [PMID: 23357341 DOI: 10.1016/j.jgg.2012.12.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
329 Gariani K, Philippe J, Jornayvaz FR. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside. Diabetes Metab. 2013;39:16-26. [PMID: 23266468 DOI: 10.1016/j.diabet.2012.11.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 73] [Article Influence: 6.9] [Reference Citation Analysis]
330 Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic Fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34:84-129. [PMID: 23238855 DOI: 10.1210/er.2012-1009] [Cited by in Crossref: 132] [Cited by in F6Publishing: 144] [Article Influence: 13.2] [Reference Citation Analysis]
331 Kursawe R, Caprio S, Giannini C, Narayan D, Lin A, D'Adamo E, Shaw M, Pierpont B, Cushman SW, Shulman GI. Decreased transcription of ChREBP-α/β isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia. Diabetes 2013;62:837-44. [PMID: 23209190 DOI: 10.2337/db12-0889] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 7.6] [Reference Citation Analysis]
332 Cornford AS, Hinko A, Nelson RK, Barkan AL, Horowitz JF. Rapid development of systemic insulin resistance with overeating is not accompanied by robust changes in skeletal muscle glucose and lipid metabolism. Appl Physiol Nutr Metab 2013;38:512-9. [PMID: 23668758 DOI: 10.1139/apnm-2012-0266] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
333 Erion DM, Popov V, Hsiao JJ, Vatner D, Mitchell K, Yonemitsu S, Nagai Y, Kahn M, Gillum MP, Dong J, Murray SF, Manchem VP, Bhanot S, Cline GW, Shulman GI, Samuel VT. The role of the carbohydrate response element-binding protein in male fructose-fed rats. Endocrinology 2013;154:36-44. [PMID: 23161873 DOI: 10.1210/en.2012-1725] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
334 Ortinau LC, Pickering RT, Nickelson KJ, Stromsdorfer KL, Naik CY, Haynes RA, Bauman DE, Rector RS, Fritsche KL, Perfield JW 2nd. Sterculic Oil, a Natural SCD1 Inhibitor, Improves Glucose Tolerance in Obese ob/ob Mice. ISRN Endocrinol 2012;2012:947323. [PMID: 23209931 DOI: 10.5402/2012/947323] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
335 Błachnio-Zabielska AU, Baranowski M, Hirnle T, Zabielski P, Lewczuk A, Dmitruk I, Górski J. Increased bioactive lipids content in human subcutaneous and epicardial fat tissue correlates with insulin resistance. Lipids 2012;47:1131-41. [PMID: 23054552 DOI: 10.1007/s11745-012-3722-x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
336 Jelenik T, Roden M. Mitochondrial plasticity in obesity and diabetes mellitus. Antioxid Redox Signal 2013;19:258-68. [PMID: 22938510 DOI: 10.1089/ars.2012.4910] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
337 Theytaz F, Noguchi Y, Egli L, Campos V, Buehler T, Hodson L, Patterson BW, Nishikata N, Kreis R, Mittendorfer B. Effects of supplementation with essential amino acids on intrahepatic lipid concentrations during fructose overfeeding in humans. Am J Clin Nutr. 2012;96:1008-1016. [PMID: 23034968 DOI: 10.3945/ajcn.112.035139] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 5.7] [Reference Citation Analysis]
338 Jornayvaz FR, Shulman GI. Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance. Cell Metab 2012;15:574-84. [PMID: 22560210 DOI: 10.1016/j.cmet.2012.03.005] [Cited by in Crossref: 193] [Cited by in F6Publishing: 385] [Article Influence: 19.3] [Reference Citation Analysis]
339 Farese RV  Jr., Zechner R, Newgard CB, Walther TC. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab 2012; 15: 570-573. [PMID: 22560209 DOI: 10.1016/j.cmet.2012.03.004] [Cited by in Crossref: 153] [Cited by in F6Publishing: 157] [Article Influence: 15.3] [Reference Citation Analysis]
340 Glass CK, Olefsky JM. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 2012;15:635-645. [PMID: 22560216 DOI: 10.1016/j.cmet.2012.04.001] [Cited by in Crossref: 491] [Cited by in F6Publishing: 503] [Article Influence: 49.1] [Reference Citation Analysis]
341 Nobili V, Bedogni G, Berni Canani R, Brambilla P, Cianfarani S, Pietrobelli A, Agostoni C. The potential role of fatty liver in paediatric metabolic syndrome: a distinct phenotype with high metabolic risk? Pediatr Obes 2012;7:e75-80. [PMID: 23001964 DOI: 10.1111/j.2047-6310.2012.00089.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
342 Brown WH, Gillum MP, Lee HY, Camporez JP, Zhang XM, Jeong JK, Alves TC, Erion DM, Guigni BA, Kahn M, Samuel VT, Cravatt BF, Diano S, Shulman GI. Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism. Proc Natl Acad Sci U S A 2012;109:14966-71. [PMID: 22912404 DOI: 10.1073/pnas.1212887109] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
343 Sun Z, Miller RA, Patel RT, Chen J, Dhir R, Wang H, Zhang D, Graham MJ, Unterman TG, Shulman GI. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med. 2012;18:934-942. [PMID: 22561686 DOI: 10.1038/nm.2744] [Cited by in Crossref: 222] [Cited by in F6Publishing: 221] [Article Influence: 22.2] [Reference Citation Analysis]
344 Wu X, Chen K, Williams KJ. The role of pathway-selective insulin resistance and responsiveness in diabetic dyslipoproteinemia: . Current Opinion in Lipidology 2012;23:334-44. [DOI: 10.1097/mol.0b013e3283544424] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
345 Hardy OT, Czech MP, Corvera S. What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes. 2012;19:81-87. [PMID: 22327367 DOI: 10.1097/med.0b013e3283514e13] [Cited by in Crossref: 284] [Cited by in F6Publishing: 259] [Article Influence: 28.4] [Reference Citation Analysis]
346 Bonora E, Targher G. Increased risk of cardiovascular disease and chronic kidney disease in NAFLD. Nat Rev Gastroenterol Hepatol. 2012;9:372-381. [PMID: 22565095 DOI: 10.1038/nrgastro.2012.79] [Cited by in Crossref: 85] [Cited by in F6Publishing: 77] [Article Influence: 8.5] [Reference Citation Analysis]
347 Benhamed F, Denechaud PD, Lemoine M, Robichon C, Moldes M, Bertrand-Michel J, Ratziu V, Serfaty L, Housset C, Capeau J, Girard J, Guillou H, Postic C. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans. J Clin Invest 2012;122:2176-94. [PMID: 22546860 DOI: 10.1172/JCI41636] [Cited by in Crossref: 236] [Cited by in F6Publishing: 247] [Article Influence: 23.6] [Reference Citation Analysis]
348 Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148:852-871. [PMID: 22385956 DOI: 10.1016/j.cell.2012.02.017] [Cited by in Crossref: 1261] [Cited by in F6Publishing: 1257] [Article Influence: 126.1] [Reference Citation Analysis]
349 Renner S, Römisch-Margl W, Prehn C, Krebs S, Adamski J, Göke B, Blum H, Suhre K, Roscher AA, Wolf E. Changing metabolic signatures of amino acids and lipids during the prediabetic period in a pig model with impaired incretin function and reduced β-cell mass. Diabetes 2012;61:2166-75. [PMID: 22492530 DOI: 10.2337/db11-1133] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 3.8] [Reference Citation Analysis]
350 Torres DM, Williams CD, Harrison SA. Features, diagnosis, and treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012;10:837-58. [PMID: 22446927 DOI: 10.1016/j.cgh.2012.03.011] [Cited by in Crossref: 171] [Cited by in F6Publishing: 155] [Article Influence: 17.1] [Reference Citation Analysis]
351 Papackova Z, Palenickova E, Dankova H, Zdychova J, Skop V, Kazdova L, Cahova M. Kupffer cells ameliorate hepatic insulin resistance induced by high-fat diet rich in monounsaturated fatty acids: the evidence for the involvement of alternatively activated macrophages. Nutr Metab (Lond) 2012;9:22. [PMID: 22439764 DOI: 10.1186/1743-7075-9-22] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
352 Magkos F, Su X, Bradley D, Fabbrini E, Conte C, Eagon JC, Varela JE, Brunt EM, Patterson BW, Klein S. Intrahepatic diacylglycerol content is associated with hepatic insulin resistance in obese subjects. Gastroenterology. 2012;142:1444-1446.e2. [PMID: 22425588 DOI: 10.1053/j.gastro.2012.03.003] [Cited by in Crossref: 122] [Cited by in F6Publishing: 121] [Article Influence: 12.2] [Reference Citation Analysis]
353 Samocha-Bonet D, Chisholm DJ, Tonks K, Campbell LV, Greenfield JR. Insulin-sensitive obesity in humans - a 'favorable fat' phenotype? Trends Endocrinol Metab 2012;23:116-24. [PMID: 22284531 DOI: 10.1016/j.tem.2011.12.005] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 7.5] [Reference Citation Analysis]
354 Zhang C, Wendel AA, Keogh MR, Harris TE, Chen J, Coleman RA. Glycerolipid signals alter mTOR complex 2 (mTORC2) to diminish insulin signaling. Proc Natl Acad Sci U S A 2012;109:1667-72. [PMID: 22307628 DOI: 10.1073/pnas.1110730109] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
355 Bergman BC, Hunerdosse DM, Kerege A, Playdon MC, Perreault L. Localisation and composition of skeletal muscle diacylglycerol predicts insulin resistance in humans. Diabetologia. 2012;55:1140-1150. [PMID: 22252470 DOI: 10.1007/s00125-011-2419-7] [Cited by in Crossref: 106] [Cited by in F6Publishing: 107] [Article Influence: 10.6] [Reference Citation Analysis]
356 Jurczak MJ, Lee AH, Jornayvaz FR, Lee HY, Birkenfeld AL, Guigni BA, Kahn M, Samuel VT, Glimcher LH, Shulman GI. Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice. J Biol Chem 2012;287:2558-67. [PMID: 22128176 DOI: 10.1074/jbc.M111.316760] [Cited by in Crossref: 117] [Cited by in F6Publishing: 117] [Article Influence: 10.6] [Reference Citation Analysis]